title: Exo

first: HONGWEI

last: LIANG

state: Jiangsu Province

address: Qixia District, Xianlin Road No.163

institute: Nanjing University

description: miRNAs in exosomes

hyb_protocol: 1.5 ug of Cy3-labelled cRNA (specific activity >10.0 pmol Cy3/ug cRNA) was fragmented at 60°C for 30 minutes in a reaction volume of 250 ml containing 1x Agilent fragmentation buffer and 2x Agilent blocking agent following the manufacturers instructions. On completion of the fragmentation reaction, 250 ml of 2x Agilent hybridization buffer was added to the fragmentation mixture and hybridized to Agilent Whole Human Genome Oligo Microarrays (G4112A) for 17 hours at 65Â°C in a rotating Agilent hybridization oven.  After hybridization, microarrays were washed 1 minute at room temperature with GE Wash Buffer 1 (Agilent) and 1 minute with 37Â°C GE Wash buffer 2 (Agilent), then dried immediately by brief centrifugation.

scan_protocol: Slides were scanned immediately after washing on Agilent Scanner G5761A(Agilent Technologies) using one color scan setting for 1x44k array slides (Scan Area 61x21.6 mm, Scan resolution 10um, Dye channel is set to Green and Green PMT is set to 100%).

data_processing: The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default parameters (protocol GE1-v1_91 and Grid: 012391_D_20060331) to obtain background subtracted and spatially detrended Processed Signal intensities.  Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.

source_name: exosomes

label_protocol: Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the One-Color Low RNA Input Linear Amplification PLUS kit (Agilent) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).  Dye incorporation and cRNA yield were checked with the NanoDrop ND-1000 Spectrophotometer.

extract_protocol: RNA was prepared using Trizol regeant following the manufacturer's recommendations. RNA was quantified using a NanoDrop-1000 spectrophotometer and quality was monitored with the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA).

treatment_protocol: migrasomes and exosomes were isolated ultracentrifugation.

value: exosomes


title: Core_fibrils_Passage T5_replicate A

status: Public on May 14 2020

type: RNA

city: Mumbai

first: Samir

last: Maji

address: Indian Institute of Technology Bombay, Powai

department: Biosciences and Bioengineering

country: India

institute: Indian Institute of Technology Bombay

description: Gene expression after treatment with treated with 30 µM of p53 core fibrils for passage T5, replicate A

hyb_protocol: Labeled cRNA sample were fragmented at 60ºC and hybridized on to a Agilent Human Gene  Expression Microarray 8X60K. Fragmentation of labeled cRNA and hybridization were done  using the Gene Expression Hybridization kit of (Agilent Technologies, In situ Hybridization kit,  Part Number 5190-0404). Hybridization was carried out in Agilent’s Surehyb Chambers at 65º C  for 16 hours. The hybridized slides were washed using Agilent Gene Expression wash buffers  (Agilent Technologies, Part Number 5188-5327).

scan_protocol: The hybridized slides were washed using Agilent Gene Expression wash buffers  (Agilent Technologies, Part Number 5188-5327) and scanned using the Agilent Microarray  Scanner (Agilent Technologies, Part Number G2600D).

data_processing:
Data extraction, dye normalization, and spatial derendering were done using default settings of the Agilent Feature Extractor and feature extracted raw data was analyzed using Agilent GeneSpring GX (v14.5) software.
Significant genes up regulated with fold change >=1  (logbase2) and down regulated with fold change <=-1 (logbase2) in the test samples with respect  to control sample were identified across the biological replicates.

molecule: total RNA

organism: Homo sapiens

source_name: MCF10A cells treated with p53 core fibrils and RNA was collected after 5 rounds of passaging (T5).

label_protocol: The samples for Gene expression were  labeled using Agilent Quick-Amp labeling Kit (p/n5190-0442). The total RNA were reverse  transcribed at 40°C using oligo dT primer tagged to a T7 polymerase promoter and converted to  double stranded cDNA. Synthesized double stranded cDNA were used as template for cRNA  generation. cRNA was generated by in vitro transcription and the dye Cy3 CTP(Agilent) was  incorporated during this step. The cDNA synthesis and in vitro transcription steps were carried  out at 40°C. Labeled cRNA was cleaned up using Qiagen RNeasy columns (Qiagen, Cat No:  74106) and quality assessed for yields and specific activity using the Nanodrop ND-1000.

growth_protocol: MCF10A cells were cultured in DMEM growth medium supplemented with 5% horse serum, 0.5 μg/ml hydrocortisone, 20 ng/ml hEGF, 10 μg/ml insulin and 1X Pen-Strep at 37 °C in a 5 % CO2 incubator.

extract_protocol: RNA was extracted using Qiagen Rneasy kit according to the manufacturers instructions.

treatment_protocol: For fibril treatment,DMEM containing 30 µM of p53 core fibrils were added alongwith other supplements were added and cells were incubated for 48 hours at 37 °C in a 5 % CO2 incubator.

tag: cell line

tag: tissue

value: breast

tag: gender

value: female

tag: age

value: Passage T5

tag: treatment

value: p53 core fibrils


title: LNCaP 10nM DHT 1

city: Gaithersburg

first: Kalpit

last: Shah

state: MD

address: 8717 Grovemont Cir

country: USA

institute: DCEG

hyb_protocol: as per manufacturer's recommendatin (HTA-2.0)

scan_protocol: fluorescence intensity of the arrays was scanned using the Affymetrix Scanner and the raw data

data_processing: TAC console

label: biotin

source_name: LNCaP0nM DHT

growth_protocol: Grown for 72 hours in RPMI-1640 10% CSFBS media

extract_protocol: RNA was extracted using the RNeasy mini kit

treatment_protocol: Treated with either 10nM DHT, 10uM Casodex or DMSO

value: Prostate

value: LNCaP

value: DHT


title: KO sample 3

type: SRA

city: Amsterdam

first: Veronika

last: Ramovs

address: Plesmanlaan 121

department: Cell Biology

country: Netherlands

institute: Netherlands Cancer Institute

library_source: transcriptomic

data_processing:
The strand-specific reads (65bp single-end) were sequenced using the Illumina HiSeq2500 machine. Demultiplexing of the reads was performed with Illumina's bcl2fastq.
Demultiplexed reads were aligned against the mouse reference genome (build 38) using TopHat (version 2.1.0, bowtie 1.1).
TopHat was supplied with a known set of gene models (Gene Transfer Format file (GTF) Ensembl version 77) and was guided to use the first-strand as the library-type. As additional parameters --prefilter-multihits and --no coverage were used.
Genecounts were generated using a custom script that gives the same output as HTSeq-count.
Genome_build: Mouse Build 38
Supplementary_files_format_and_content: genecounts.txt

organism: Mus musculus

source_name: epidermis

extract_protocol:
Mouse epidermis was isolated and resuspended GFP-positive keratinocytes were FACS sorted to RLT buffer (Qiagen) and stored at -80°C until further processing
Strand-specific libraries were generated using the TruSeq Stranded mRNA sample preparation kit according to the manufacturer’s instructions.

treatment_protocol: 6 weeks old mice were shaved and injected with 10mg/ml of tamoxifen over 4 days. At the age of 7 weeks, mice were treated with one dose of DMBA (30ug in 200ul of acetone), followed by tto weeks of bi-weekly applications of TPA (12.34ug in 200ul of acetone)

tag: cell type

value: keratinocytes

tag: strain and genotype

value: 19(Cre-ERT); mTmG; Itga3 fl/fl bred on FVB

value: epidermis

value: short-term DMBA/TPA treated


title: Human-EVs-5 [B5_EV]

city: Baltimore

first: Kenneth

middle: W.

last: Witwer

address: 733 N. Broadway

department: Department of Molecular and Comparative Pathobiology

institute: Johns Hopkins University School of Medicine

description:
IonXpressRNA_044_rawlib.basecaller_B5_EV
processed data file: Human_combined_raw_counts.xlsx

data_processing:
FASTQC run before and after adapter trimming. The reads were aligned to the reference transcriptomes in a sequential manner.   First, all reads were mapped to RNA species with low sequence complexity and/or high number of repeats: rRNA, tRNA, RN7S, snRNA, snoRNA, scaRNA, VT-RNA, Y-RNA as well as mitochondrial chromosome (mtRNA). All reads that did not map to the above RNAs were aligned to premiRNA reference, then to protein coding mRNA transcripts (pc) and long non-coding RNAs (lncRNAs). Please note that some % of reads always overlaps between pc and lncRNAs. The reads which did not map to premiRNA, protein coding (pc) transcripts and lncRNAs were aligned to the remaining transcriptome [other ncRNAs containing mostly pseudogenes and non-protein coding parts of mRNAs]. Finally, all reads which did not map to human transcriptome were aligned to the hg38 genome reference (rest_hg38).
The mapping was performed with bowtie2 default settings for all references except premiRNA. For premiRNA alignment I used sequential mapping with bowtie using settings with: 0 mismatch tolerance, then 1 mismatch tolerance and finally 2 mismatches tolerance.
Genome_build: Hg38
Supplementary_files_format_and_content: raw counts

source_name: Human-Evs

extract_protocol: Small RNA libraries were constructed using the Ion Total RNA-Seq Kit V2 (Life Technologies 4475936).

value: Brain

tag: tissue type

value: Parietal cortex

value: EV fraction from 10,000 x g supernatant after SEC and ultracentrifugation


title: Mi

city: Nanjing

country: China

description: miRNAs in migrasomes

source_name: migrasomes

value: migrasomes


title: Kidney_DKD_rep4

city: Tokyo

first: Sho

last: Hasegawa

address: 7-3-1, Hongo, Bunkyo-ku

department: Division of Nephrology and Endocrinology

country: Japan

institute: University of Tokyo

description: Gene expression of renal cortex in DKD group

hyb_protocol: 0.6 ug of Cy3-labelled cRNA was fragmented at 60°C for 30 minutes in a Agilent fragmentation buffer and was hybridized at 65°C for 17 hr using Gene Expression Hybridization Kit.

scan_protocol: Microarray slides were scanned at 3 μm resolution using an Agilent G4900DA SureScan Microarray Scanner System.

data_processing: The intensity data of each individual hybridization were extracted and the quality was assessed with the Feature Extraction Software 11.5.1.1(Agilent). Raw data were processed with the R package limma in Bioconductor to perform background correction and data normalization using the quantile normalization method, and batch effects were removed by ComBat (batch 1; SAMPLE 1, 2, 6, 7, 13, 14, batch 2; SAMPLE 3, 4, 8, 9, 15, 16, batch 3; SAMPLE 5, 10, 11, 12, 17, 18, 19).

organism: Rattus norvegicus

source_name: Renal cortex, DKD, replicate 4

label_protocol: Agilent one-color Microarray-Based Gene Expression Analysis Low Input Quick Amp Labeling protocol

extract_protocol: Total RNA from kidney cortical tissue was isolated using GenElute Mammalian Total RNA Miniprep Kit (RTN70, Sigma-Aldrich). RNA was quantified using a NanoDrop-1000 spectrophotometer and quality was monitored with the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA).

value: Renal cortex

tag: strain

value: Crl:CD (SD)

value: male

tag: group

value: DKD


title: dnsdC_16h_control_2

city: Ribeirao Preto

first: Gustavo

middle: Henrique

last: Goldman

state: Sao Paulo

address: Avenida do Cafe

country: Brazil

institute: Sao Paulo University

description:
Chromatin
ΔnsdC control (untreated)

library_source: genomic

data_processing:
Raw data was aligned to A. fumigatus reference genome using Bowtie2 v2.3.5 tool. Initial 8bp of reads were clipped during mapping step using argument "bowtie2  --trim5 8 --local  "
Normalized the reads depth to 1 million mapped reads using "macs2 bdgopt " command from MACS2 v2.1.1
Converted bedGraph files to bigWig files using UCSC Kent Utils v369 tool "bedGraphToBigWig"
Normalized PolII signal (FPKM) was calculated for all the genes using inhouse Perl script
Genome_build: Aspergillus fumigatus Af293 reference genome from AspGD. Version s03-m05-r06
Supplementary_files_format_and_content: bigwig files were generated using UCSC Kent Utils v369; Scores represent normalized read depth to 1 million reads

molecule: genomic DNA

organism: Aspergillus fumigatus

source_name: cultured colonies

growth_protocol: CEA17 and ∆nsdC strains conidia (1.10^7) were grown into liquid AMM for 16 h at 37oC under shaking conditions.

extract_protocol:
The micelia were lysed in 800 μl of FA lysis buffer for 3 min (6 times) using a Bullet Blender and  sonicated using the Qsonica Q800R at 100% amplitude with 10 seconds ON and 15 seconds OFF cycles for a total sonication time of 30 minutes.
Library preparation was carried out using NEBNext® Ultra II Library Prep kit (Illumina, cat. no. E7645L) according to manufacturer’s protocol.

treatment_protocol: After 16 h of growth, calcium samples were treated for 10 minutes with 200mM of calcium chloride, crosslinked (formaldehyde 1% for 20 min, then glycine 1M for 10min), washed with cold water for 2 times and collected; control samples were crosslinked, washed and collected after 16h of growth.

value: ΔnsdC [ΔnsdC::pyrG, akuB (KU80)Δ, MAT1-1]

tag: tag

value: untagged

tag: chip antibody

value: anti-RNA polymerase II subunit antibodies (clone 3E8, Millipore)


title: KO sample 1


title: dnsdC_16h_control_1

description:
Chromatin
ΔnsdC control (untreated)


title: WT sample 3

value: 19(Cre-ERT); mTmG bred on FVB


title: LNCaP DMSO 1

source_name: LNCaP DMSO

label_protocol: as per manufacturer's recommendatin (HTA-2.0)

value: Prostate

value: LNCaP

value: DMSO


title: LNCaP DMSO 3


title: LNCaP 10uM bicul 3

source_name: LNCaP0uM bicul

value: Bicalutamide (Casodex)


title: dnsdC_16h_calcium_1

description:
Chromatin
ΔnsdC treated with calcium


title: Human-EVs-4 [B4_EV]

description:
IonXpressRNA_043_rawlib.basecaller_B4_EV
processed data file: Human_combined_raw_counts.xlsx


title: dnsdC_16h_calcium_2

description:
Chromatin
ΔnsdC treated with calcium


title: Kidney_DKD_rep2

source_name: Renal cortex, DKD, replicate 2


title: Kidney_DKD_rep1

source_name: Renal cortex, DKD, replicate 1


title: Kidney_DKD_rep3

source_name: Renal cortex, DKD, replicate 3


title: Kidney_Sham_rep5

description: Gene expression of renal cortex in sham group

source_name: Renal cortex, Sham, replicate 5

value: sham


title: KO sample 2

value: keratinocytes

value: 19(Cre-ERT); mTmG; Itga3 fl/fl bred on FVB

value: epidermis

value: short-term DMBA/TPA treated


title: CEA17_16h_control_2

description:
Chromatin
CEA17 control (untreated)

value: CEA17 [akuB (KU80)Δ, MAT1-1]


title: Human-EVs-2 [B2_EV]

description:
IonXpressRNA_041_rawlib.basecaller_B2_EV
processed data file: Human_combined_raw_counts.xlsx

value: Brain

value: Parietal cortex

value: EV fraction from 10,000 x g supernatant after SEC and ultracentrifugation


title: WT sample 1


title: CEA17_16h_control_1

description:
Chromatin
CEA17 control (untreated)


title: Human-EVs-1 [B1_EV]

description:
IonXpressRNA_040_rawlib.basecaller_B1_EV
processed data file: Human_combined_raw_counts.xlsx


title: Human-10K-7 [B7_10K]

description:
IonXpressRNA_046_rawlib.basecaller_B7_10K
processed data file: Human_combined_raw_counts.xlsx

value: 10,000 x g pellet from digested tissue


title: CEA17_16h_calcium_2

description:
Chromatin
CEA17 treated with Calcium

value: untagged


title: Human-10K-6 [B6_10K]

description:
IonXpressRNA_045_rawlib.basecaller_B6_10K
processed data file: Human_combined_raw_counts.xlsx


title: Human-EVs-3 [B3_EV]

description:
IonXpressRNA_042_rawlib.basecaller_B3_EV
processed data file: Human_combined_raw_counts.xlsx


title: Human-10K-5 [B5_10K]

description:
IonXpressRNA_044_rawlib.basecaller_B5_10K
processed data file: Human_combined_raw_counts.xlsx


title: CD21_5 iPMP

city: Stanford

first: Robert

middle: Raymond

last: Butler

state: CA

address: 3172 Porter Dr., MC 5475

department: Neurology & Neurological Sciences

institute: Stanford University School of Medicine

data_processing:
Read trimming with Trimmomatic v0.36 argurments(PE IILUMINACLIP:$adapters:2:30:10 LEADING:30 TRAILING:30 SLIDINGWINDOW:4:15 MINLEN:20)
Read mapping with STAR 2.6.1d arguments(--outSAMtype BAM SortedByCoordinate --bamRemoveDuplicatesType UniqueIdentical --outFilterIntronMotifs RemoveNoncanonical --outFilterMismatchNmax 2 --outFilterScoreMinOverLread 0.30 --outFilterMatchNminOverLread 0.30 --alignSoftClipAtReferenceEnds No)
Counts with featureCounts 1.6.3 arguments(-p -B -C -D 2000 -t gene)
Genome_build: GRCh38 Release-94
Supplementary_files_format_and_content: Raw feature count expression matrix for all samples submitted

growth_protocol: CD0000011 (CD11) and CD0000021 (CD21) hiPSC lines were used to generated iMG. We followed the Brownjohn et al method.  These cell lines were cultured in mTeSR complete medium (85850, STEMCELL) with 2 ml daily media change.  At least two days after passaging, iPSCs were passaged to single cells and plated at 10,000 cells per well in 96-well round bottom ultra-low attachment plates (Corning) in 100 ul EB media and plates were centrifuged at 300g for 3 min. EB media was prepared by adding to the complete mTeSR media BMP-4 (Thermofisher), SCF (Thermofisher), VEGF-121 (Peprotech) and ROCK inhibitor (Tocris). Cells were cultured for four days, with half media change after two days. On day four, 16 EBs were plated on a 6-well plate and cultured in 3 ml hematopoietic media with 2 ml media exchanges every five days. Hematopoietic media was prepared by adding to the X-VIVO 15 (04-744Q, Lonza) GlutaMax (Thermofisher), Pen/strep (Thermofisher), β-mercaptoethanol (Sigma), M-CSF (Thermofisher) and IL-3 (Thermofisher). After five days culturing EBs in hematopoietic media, PMPs started to appear in the suspension and were produced continuously in suspension for 34 days. After 10 days of culturing EBs, PMPs could be harvested from suspension and plated in RPMI 1640 (Thermofisher) at 180,000 cells/cm2 in 6- or 12-well plates. After one hour, PMPs adhered to surface and media was changed to complete microglia media. Full media changes were done every 2 days. Complete microglia media was prepared with RPMI 1640 by adding FBS (Thermofisher), Glutamax, Pen/strep, IL-24 (PeptroTech) and GM-CSF (PeproTech). Final differentiation of PMPs into microglia occurred over 6-10 days and cells could be kept for at least one month in this format.

extract_protocol:
Total RNA from each stem cell line after PBS wash. Cells were lysed in RLT plus buffer, and total RNA extracted with the RNeasy mini kit (Qiagen). cDNA was reverse transcribed from RNA with a high-capacity cDNA reverse transcription kit (Applied Biosystems).
Total RNA was sent for sequencing to Novogene (en.novogene.com). Sequencing libraries were prepared using the NEB Nextera kit with customized adapters.

tag: cell line background

value: human induced pluripotent stem cell (hiPSC) line

tag: cell subtype

value: CD21 hiPSC-derived primitive macrophage precursors day 16 after plating Ebs


title: 229_07_Vehicle+proclactin

city: Chuo-ku, Kobe

first: Bakhtiyor

last: Nosirov

state: Hyogo

address: Minatojima-minamimachi, 2-2-3

institute: BDR RIKEN, Japan

data_processing:
51 bp single end sequencing run with Illumina HiSeq 3000 platform and CASAVA was employed to generate the fastq file for each sample
RNA-seq FASTQ files were aligned to hg19 using TopHat (version 2.0.14) and only uniquely mapped reads were used for the further downstream analysis
summarizeOverlaps function (of GenomicAlignments package) in R/Bioconductor was utilized to count the reads that mapped to exonic regions only to generate a raw count matrix
DESeq2, whose default and recommended normalization method is relative log expression (RLE), was then utilized to identify differentially expressed genes (DEGs). The genes with log2FoldChange>=1, after rounding all log2FoldChange values to one decimal point, and adjusted p-value<0.05 were considered DEGs
Functional annotation of DEGs was performed using ClueGO (v2.5.4) plug-in of Cytoscape
Genome_build: hg19
Supplementary_files_format_and_content: read counts

source_name: T47D breast cancer cells

growth_protocol: Cell were maintained and passed in appropriate culture media, as described in the manuscript.

extract_protocol:
RNA was extracted using Trizol
RNA libraries were prepared for sequencing using standard Illumina protocols

treatment_protocol: T47D breast cancer cells were treated with vehicle (water for prolactin and EtOH for R5020), 100 ng/ml prolactin, 10nM R5020, or both, for 6 hrs. RNA was isolated immediately following treatment.

value: breast cancer cells


title: NbBsmI-nickase-TdT

city: Singapore

first: Xiaolin

last: Wu

state: Singapore

address: 1 CREATE Way

country: Singapore

institute: Singapore-MIT Alliance for Research and Technology (SMART)

data_processing:
Sequencing results were processed on the Galaxy web platform (https://usegalaxy.org/). Initially, the paired end reads were pre-processed by trim galore to remove adapters and the first 3 bp on the 5’ of read 1 were also trimmed.
All the reads were aligned to the corresponding genome using Bowtie 2.
A custom method for peak calling of sequencing data was developed with BamTools, BEDTools and Rstudio. Briefly, the bam results were filtered based on R1 (selected for nick translation data) or R2 (selected for 3’ capture data). The 5’ coverage (experiment sample) or full coverage (controls) on each position were calculated based on the filtered bam result by BEDTools(positive and negative strand separately)
The coverage of positionN (sample)/ coverage of positionN-1(sample), coverage of positionN(sample)/ coverage of positionN+1(sample) and coverage of positionN(sample)/ coverage of positionN(control)  ratio was calculated on each position and the positions with all the three ratios above 5 were regarded as strong signals.
Genome_build: NC_010473.1
Supplementary_files_format_and_content: tabular files were generated by BEDTools containing the 5’ coverage (experiment sample) or full coverage (controls) on each position (positive and negative strand separately)

organism: Escherichia coli str. K-12 substr. DH10B

source_name: bacteria

growth_protocol: E. coli K12 strains were grown in Luria-Bertani (LB) at 37 °C.

extract_protocol:
R1:Nick translation of genomic DNA. After creation or conversion of the interested sites into nick sites, split the DNA samples equally into two tubes: one for nick translation and the other for negative control. The nick translation was performed in a 50 μl reaction system containing 2 μl of alpha-thio-dNTPs (2.5 mM each, TRILINK), 1X of NEBcutsmart buffer, 2 μl of DNA polymerase I and DNA template. For the negative control, used H2O instead of DNA polymerase I. The reaction mixture was incubated at 15 °C for 90 min and then terminated by heating at 75 °C for 20 min. The product was ready of template DNA digestion after the purification by DyeEx.  Genomic DNA template digestion. The DNA product from nick translation was digested by Exonuclease III (NEB) and RecJf (NEB) to remove the template DNA. A 50 μl reaction system containing 200 units Exonuclease III, 5 μl NEBcutsmart buffer and DNA product from nick translation was incubated at 37 °C for 60 min to digest double-stranded DNA template. Incubate the reaction at 95 °C for 3 min and then put on ice immediately to denature DNA. And then add 60 units of RecJf, incubate at 37 °C for 60 min. For some DNA samples with high complexity of structure and/or modifications, additional digestion with 60 units of RecJf might be necessary. After digestion, inactivate the enzymes by incubation at 80 °C for 10 min. The product was then purified by Zymo Oligo clean & concentrator kit (Zymo) following the manufacturer’s protocol. The purified product was ready for Illumina library preparation.   Nick translation of genomic DNA. After creation or conversion of the interested sites into nick sites, split the DNA samples equally into two tubes: one for nick translation and the other for negative control. The nick translation was performed in a 50 μl reaction system containing 2 μl of alpha-thio-dNTPs (2.5 mM each, TRILINK), 1X of NEBcutsmart buffer, 2 μl of DNA polymerase I and DNA template. For the negative control, used H2O instead of DNA polymerase I. The reaction mixture was incubated at 15 °C for 90 min and then terminated by heating at 75 °C for 20 min. The product was ready of template DNA digestion after the purification by DyeEx.  Genomic DNA template digestion. The DNA product from nick translation was digested by Exonuclease III (NEB) and RecJf (NEB) to remove the template DNA. A 50 μl reaction system containing 200 units Exonuclease III, 5 μl NEBcutsmart buffer and DNA product from nick translation was incubated at 37 °C for 60 min to digest double-stranded DNA template. Incubate the reaction at 95 °C for 3 min and then put on ice immediately to denature DNA. And then add 60 units of RecJf, incubate at 37 °C for 60 min. For some DNA samples with high complexity of structure and/or modifications, additional digestion with 60 units of RecJf might be necessary. After digestion, inactivate the enzymes by incubation at 80 °C for 10 min. The product was then purified by Zymo Oligo clean & concentrator kit (Zymo) following the manufacturer’s protocol. The purified product was ready for Illumina library preparation.   R2:Mapping of modification/damage sites on DNA by TdT-dependent method. The steps of DNA fragmentation, blocking and nick conversion were same as described above. 100ng of the nick converted DNA was denatured by heating at 95 °C for 3 min in 20 μl H2O, followed by Illumina library preparation with the Clontech SMART ChIp-seq kit (Clontech) by following the manufacturer’s protocol. 12 cycles were used in the final step of PCR amplification.
Illumina library preparation. Illumina library preparation was performed by the Clontech SMART ChIp-seq kit (Clontech) by following the manufacturer’s protocol. 12 cycles were used in the final step of PCR amplification. The PCR product from each sample was combined with its corresponding negative control and then size selected using AMPure XP beads (NEB). The purified library was submitted to Illumina instrument for paired-end sequencing.

treatment_protocol: 1.Fragmentation of genomic DNA.  To ensure a relatively random fragmentation of genomic DNA, 1 μg of the extracted DNA was digested separately by three DNA endonuclease combinations: NciI; HindIII and XhoI; SalI, XbaI and NdeI. RNase A was also added to each digestion mixture to remove any trace of contaminated RNA. After digestion, the digested products were purified by Qiagen PCR purification Kit. The three purified DNA sample were mixed together for the following blocking step.  2.Blocking of pre-existing strand break sites. Reaction mixture (40 μl) containing 4 μl of reaction buffer (NEBcutsmart buffer); 1 μl of Shrimp Alkaline Phosphatase (rSAP, NEB), 1 μg of template genomic DNA was incubated at 37 °C for 30 min to remove any pre-existing strand breaks with 3' end phosphate, then 70°C for 10min to inactivate rSAP. After cool down the reaction product to room temperature, add 2 μl of ddNTPs (2.5 mM each, TriLink) and 1 μl of DNA polymerase I (10 U, NEB), incubate at 37 °C for 40 min to block any pre-existing strand break sites. Then 1 μl of Shrimp Alkaline Phosphatase (rSAP, NEB) was added to the reaction mixture, incubate at 37 °C for another 30 min to degrade the excess ddNTPs. Reaction was terminated by heat-inactivation of rSAP and DNA polymerase I at 75 °C for 10 min. The reaction product was ready for one of the following nick creation or conversion procedure after de-salts by DyeEx column (QIAGEN)  3.Nick creation of E. coli DH10B genomic DNA with Nb. BsmI and Nb. BsrDI. A 50 μl reaction mixture containing 1 μl Nb. BsmI (10 U, NEB), 1 μl Nb. BsrDI (10 U, NEB), 1 μg genomic DNA and 1X NEBcutsmart buffer was incubated at 65 °C for 1 hour. The reaction was terminated by heating at 80 °C for 20 minutes and cooled down to 4 °C at the rate of 0.1 °C/s. The reaction product was used for nick translation as described below with no further purification.

tag: role

value: experiment sample

tag: library prep

value: R2-TdT dependent


title: WT sample 2

value: 19(Cre-ERT); mTmG bred on FVB


title: CEA17_16h_calcium_1

description:
Chromatin
CEA17 treated with Calcium

value: anti-RNA polymerase II subunit antibodies (clone 3E8, Millipore)


title: col+7-HC_3

city: Harbin

first: Jian

last: Wang

address: 600 Changjiang Road

institute: Northeast Agricultural University

data_processing:
BGI500 own software used for basecalling.
The sequencing data was filtered with SOAPnuke (v1.5.2) by (1) Removing reads containing sequencing adapter; (2) Removing reads whose low-quality base ratio (base quality less than or equal to 5) is more than 20%; (3) Removing reads whose unknown base ('N' base) ratio is more than 5%, afterwards clean reads were obtained and stored in FASTQ format. The clean reads were mapped to the reference genome using HISAT2 (v2.0.4). After that, Ericscript (v0.5.5) and rMATS (V3.2.5) were used to fusion genes and differential splicing genes (DSGs), respectively. Bowtie2 (v2.2.5) was applied to align the clean reads to the gene set, a database for this organism built by BGI (Beijing Genomic Institute in ShenZhen), which known and novel, coding transcripts were included, then expression level of gene was calculated by RSEM (v1.2.12). The heatmap was drawn by pheatmap (v1.0.8) according to the gene expression in different samples. Essentially, differential expression analysis was performed using the DESeq2(v1.4.5) with Q value ≤ 0.05. To take insight to the change of phenotype, GO (http://www.geneontology.org/) and KEGG (https://www.kegg.jp/) enrichment analysis of annotated different expression gene was performed by Phyper (https://en.wikipedia.org/wiki/Hypergeometric_distribution) based on Hypergeometric test . The significant levels of terms and pathways were corrected by Q value with a rigorous threshold (Q value ≤ 0.05) by Bonferroni .
Genome_build: GCF_000001635.26_GRCm38.p6
Supplementary_files_format_and_content: Excels include FPKM values for each Sample

source_name: Adult Kunming mice (female, 6 to 8 weeks, 18 to 22 g)

extract_protocol:
RNA was harvested using Trizol reagent
RNA libraries were prepared for sequencing using standard BGI500 protocols

treatment_protocol: This study aimed to investigates the renoprotective effect of 7-HC against colisitn-induced kidney injury.  Mice were randomly divided into four groups: saline solution (con group); 7-HC administered at 50 mg/kg of body weight/day (7-HC group); colistin at 15 mg/kg/day (col group); colistin at 15 mg/kg/day plus 7-HC at 50mg/kg/day (col+7-HC group). All mice were treated for 7 consecutive days, kidney tissued were collected and used to RNA sequencing.

tag: tissues

value: kidney

value: female


title: CD21_4_mixed

value: CD11 hiPSC-derived microglia contaminated with fibroblast-like cells, 100% non-microglia cells


title: col+7-HC_2

value: colistin at 15 mg/kg/day plus 7-HC at 50mg/kg/day


title: Human-10K-3 [B3_10K]

description:
IonXpressRNA_042_rawlib.basecaller_B3_10K
processed data file: Human_combined_raw_counts.xlsx


title: Kidney_Sham_rep3

source_name: Renal cortex, Sham, replicate 3

value: Renal cortex

value: Crl:CD (SD)

value: male

value: sham


title: NbBsmI-nickase-NT

value: R1-Nick translation


title: Core_fibrils_Passage T1_replicate A

description: Gene expression after treatment with treated with 30 µM of p53 core fibrils for passage T0, replicate A

source_name: MCF10A cells treated with p53 core fibrils and RNA was collected after 48h at T1.

tag: cell line

value: breast

value: Passage T1

value: p53 core fibrils


title: Macaque-6H-EVs-2 [6H_EV_M2]

description:
IonXpressRNA_051_rawlib.basecaller_M2_6H_EV
processed data file: Macaque_combined_raw_counts.xlsx

organism: Macaca nemestrina

tag: tissue

value: Brain

value: Occipital lobe

value: EV fraction from 10,000 x g supernatant after SEC and ultracentrifugation


title: Kidney_Sham_rep2

source_name: Renal cortex, Sham, replicate 2

tag: gender


title: col+7-HC_1


title: NOnickase-NT

value: negative control


title: NbBsmI-NO-TdT

value: R2-TdT dependent


title: Human-10K-2 [B2_10K]

description:
IonXpressRNA_041_rawlib.basecaller_B2_10K
processed data file: Human_combined_raw_counts.xlsx

value: Parietal cortex

value: 10,000 x g pellet from digested tissue


title: CD21_3_mixed

value: human induced pluripotent stem cell (hiPSC) line

value: CD11 hiPSC-derived microglia contaminated with fibroblast-like cells, 50% non-microglia cells


title: CD21_2_mixed

value: CD11 hiPSC-derived microglia contaminated with fibroblast-like cells, presence of many non-microglia cells


title: col_3

value: kidney

value: female

value: colistin at 15 mg/kg/day


title: Macaque-6H-EVs-1 [6H_EV_M1]

description:
IonXpressRNA_050_rawlib.basecaller_M1_6H_EV
processed data file: Macaque_combined_raw_counts.xlsx


title: CD21_1 iMG

source_name: CD21 hiPSC-derived microglia

value: CD21 hiPSC-derived microglia day 12 after plating PMPs


title: Human-10K-4 [B4_10K]

description:
IonXpressRNA_043_rawlib.basecaller_B4_10K
processed data file: Human_combined_raw_counts.xlsx


title: Human-10K-1 [B1_10K]

description:
IonXpressRNA_040_rawlib.basecaller_B1_10K
processed data file: Human_combined_raw_counts.xlsx


title: col_2


title: Macaque-6H-10K-1 [6H_10K_M1]

description:
IonXpressRNA_048_rawlib.basecaller_M1_6H_10K
processed data file: Macaque_combined_raw_counts.xlsx


title: col_1


title: Macaque-6H-10K-2 [6H_10K_M2]

description:
IonXpressRNA_051_rawlib.basecaller_M2_6H_10K
processed data file: Macaque_combined_raw_counts.xlsx


title: Kidney_Sham_rep1

source_name: Renal cortex, Sham, replicate 1

value: Renal cortex

value: Crl:CD (SD)

value: male

value: sham


title: Human-BH-7 [B7_BH]

description:
IonXpressRNA_046_rawlib.basecaller_B7_BH
processed data file: Human_combined_raw_counts.xlsx

source_name: Human-BH

value: Brain

value: Tissue homogenization


title: Kidney_Sham_rep4

description: Gene expression of renal cortex in sham group

source_name: Renal cortex, Sham, replicate 4


title: CD11_6 iMG

source_name: CD11 hiPSC-derived microglia

value: CD11 hiPSC-derived microglia day 40 after plating PMPs


title: con_3

value: saline


title: CD11_5 iMG


title: Macaque-2H-EVs-2 [2H_EV_M2]

description:
IonXpressRNA_048_rawlib.basecaller_M2_2H_EV
processed data file: Macaque_combined_raw_counts.xlsx

value: Occipital lobe

value: EV fraction from 10,000 x g supernatant after SEC and ultracentrifugation


title: Macaque-2H-EVs-1 [2H_EV_M1]

description:
IonXpressRNA_047_rawlib.basecaller_M1_2H_EV
processed data file: Macaque_combined_raw_counts.xlsx


title: con_1


title: Human-BH-4 [B4_BH]

description:
IonXpressRNA_043_rawlib.basecaller_B4_BH
processed data file: Human_combined_raw_counts.xlsx

value: Parietal cortex


title: Human-BH-3 [B3_BH]

description:
IonXpressRNA_042_rawlib.basecaller_B3_BH
processed data file: Human_combined_raw_counts.xlsx


title: Macaque-2H-10K-2 [2H_10K_M2]

description:
IonXpressRNA_050_rawlib.basecaller_M2_2H_10K
processed data file: Macaque_combined_raw_counts.xlsx

value: 10,000 x g pellet from digested tissue


title: CD11_4 iMG

value: human induced pluripotent stem cell (hiPSC) line

value: CD11 hiPSC-derived microglia day 25 after plating PMPs


title: CD11_3 iMG

value: CD11 hiPSC-derived microglia day 22 after plating PMPs


title: Macaque-2H-10K-1 [2H_10K_M1]

description:
IonXpressRNA_047_rawlib.basecaller_M1_2H_10K
processed data file: Macaque_combined_raw_counts.xlsx

source_name: Human-Evs


title: 7-HC_3

value: kidney

value: female

value: 7-HC at 50 mg/kg


title: Human-EVs-7 [B7_EV]

description:
IonXpressRNA_046_rawlib.basecaller_B7_EV
processed data file: Human_combined_raw_counts.xlsx


title: 7-HC_2


title: CD11_2 iMG

value: CD11 hiPSC-derived microglia day 12 after plating PMPs


title: CD11_7 iPMP

value: CD11 hiPSC-derived primitive macrophage precursors day 22 after plating Ebs


title: CD11_1 iMG


title: Human-BH-6 [B6_BH]

description:
IonXpressRNA_045_rawlib.basecaller_B6_BH
processed data file: Human_combined_raw_counts.xlsx


title: Human-BH-1 [B1_BH]

description:
IonXpressRNA_040_rawlib.basecaller_B1_BH
processed data file: Human_combined_raw_counts.xlsx


title: Human-BH-5 [B5_BH]

description:
IonXpressRNA_044_rawlib.basecaller_B5_BH
processed data file: Human_combined_raw_counts.xlsx


title: RA single-cell RNA-seq

city: San Francisco

first: Michael

last: Brainard

address: 675 Nelson Rising Ln

institute: University of California, San Francisco

data_processing:
Sequencing FASTQ files were aligned using cellranger v3.0.1 to the Bengalese finch genome (lonStrDom1, GenBank GCA_002197715.1) and Bengalese finch gene annotation (GenBank GCF_002197715.1) that was modified to include longer 3’ UTRs derived from previous 3’ localized sequencing
Background noise due to ambient RNA was removed using SoupX.
Cells with high mitochondrial content were removed (>25% for HVC and >40% for RA).
Genome_build: lonStrDom1, GCA_002197715.1
Supplementary_files_format_and_content: UMI counts are in a gene x cell matrix
Supplementary_files_format_and_content: metadata file contains columns with cluster identification, brain region, and several cell-level metrics (number of genes detected, mitochondrial %, etc)

molecule: polyA RNA

organism: Lonchura striata

source_name: Robust nucleus of the arcopallium

extract_protocol:
Three adult male Bengalese finches (199-203 dph) were euthanized by isoflurane overdose at 8 AM and decapitated. Brains were transferred to ice cold artificial cerebrospinal fluid (124.7 mM choline chloride, 3 mM MgSO4, 0.5 mM CaCl, 2.5 mM KCl, 25 mM NaHCO3, 35 mM glucose) bubbled with carbogen gas (95% O2, 5% CO2) then sliced from the posterior in a coronal orientation at 260 μm on a vibratome. Sections containing HVC or RA were transferred to bubbled ACSF and allowed to recover for 15 minutes. HVC and RA were identified by their known anatomical position and their dense myelination.. For each bird and region, two to three samples were manually dissected from each hemisphere and transferred to tubes containing 1 mL bubbled ACSF. 50 μL 20 mg/mL pronase (Sigma) was added to each tube, tubes were transferred to 37 °C in a shaking incubator for 45 minutes. After pronase incubation, samples were passed through three rounds of glass Pasteur pipettes fire-polished to progressively smaller pore sizes (600, 300, and 150 μm). After dissociation samples were spun down at 100xg for 1 minute at 4 °C and washed twice in ACSF containing 1% fetal bovine serum (FBS), resuspended in ACSF/1% FBS and 1 ng/mL DAPI, filtered through 40 μm FlowMi filters (Scienceware). Samples were then flow sorted to exclude cells with high DAPI intensity. After collection cells were spun down at 100xg for 1 minute at 4 °C and resuspended in 50 μL PBS with 0.04% bovine serum albumin, counted, then adjusted to a concentration of 230-400 cells / μL.
Samples were then transferred to the Gladstone Genomics Core where they were loaded onto a  Chromium controller (10X Genomics) with the Chromium Single Cell 3’ Library & Gel Bead Kit v2 (10X Genomics). Libraries were constructed according to manufacturer’s instructions with separate i7 indices then pooled.

tag: age

value: 200 days post hatch

tag: Sex

value: male


title: 7-HC_1

tag: treatment


title: con_2


title: HVC single-cell RNA-seq

source_name: HVC, letter-based proper noun


title: LNCaP 10nM DHT 2

source_name: LNCaP0nM DHT

value: Prostate

value: LNCaP

value: DHT


title: Human-BH-2 [B2_BH]

description:
IonXpressRNA_041_rawlib.basecaller_B2_BH
processed data file: Human_combined_raw_counts.xlsx

value: Brain

value: Tissue homogenization


title: Sample_262_6_hiPSC-NPC2

status: Public on May 13 2020

city: New York

middle: S

last: Breen

state: NY

address: 1468 Madison Ave

department: Depts. of Psychiatry, Genetics and Genomic Sciences

institute: Ichan School of Medicine at Mount Sinai

data_processing:
RNA samples were purified using PolyA selection, and the Illumina TruSeq Stranded Total RNA kit (Ilumina, San Diego, CA, USA) was used for library preparation, according to the manufacturer instructions.
All indexed RNA libraries were pooled and sequenced using long read paired-end chemistry (2 × 150 bp) at an average read depth of ~50M reads per sample using the Illumina HiSeq2500.
Resulting short reads with Illumina adapters were trimmed and low-quality reads were filtered using TrimGalore (--illumina option).
All high-quality reads were then processed for alignment using the hg38 reference and the ultrafast universal RNA-seq aligner STAR (v2.5.1) with default parameters. Mapped bam files were sorted using Samtools and short read data were quantified using featureCounts [47] with the following parameters: -T 5,  -t exon, -g gene_id.
Genome_build: hg37/hg19
Supplementary_files_format_and_content: Raw count data were generated with featureCounts and are provided as a separate matrix.

source_name: human induced pluripotent stem cells (hiPSCs)

extract_protocol:
RNA was extracted and purified in accordance with the PAX gene RNA kit per manufacterer's instructions. Globin mRNA was depleted from samples using GLOBINclear - Human Kit (Life Technologies, USA).
RNA libraries were prepared for sequencing using stranded Illumina Tru-Seq protocols using the Illumina HiSeq 2000.

tag: cell type

value: hiPSC-NPCs (neural progenitor cells)

value: M

tag: group/diagnosis

value: CTRL

tag: individual id

value: J

tag: rin

tag: family id

value: F

tag: timepoint


title: Sample_21_16_hiPSC-NPC3

value: PMS

value: B

value: A


title: Sample_72_14_hiPSC-NPC1

value: L

value: G


title: Sample_21_16_hiPSC-NPC1


title: Sample_72_3_hiPSC-NPC1


title: Sample_73_11_hiPSC-NPC1


title: Sample_263_3B_hiPSC-NPC2

value: K


title: Sample_21_10_hiPSC-NPC1


title: Sample_21_16B_hiPSC-NPC1


title: Sample_21_6B_hiPSC-NPC3


title: Sample_21_10_hiPSC-NPC3


title: Sample_263_3_hiPSC-NPC2


title: Sample_73_14_hiPSC-NPC1


title: Sample_73_6_hiPSC-NPC1


title: Sample_20_7_hiPSC-NPC3


title: Sample_20_3_hiPSC-NPC1


title: Sample_20_3_hiPSC-NPC3


title: Sample_20_11_hiPSC-NPC3


title: Sample_20_7_hiPSC-NPC1


title: Sample_20_11_hiPSC-NPC1


title: Sample_188_3_hiPSC-NPC2

value: I

value: E


title: Sample_21_6_hiPSC-NPC1


title: Sample_262_3_hiPSC-NPC2


title: Sample_21_6_hiPSC-NPC3


title: Sample_120_4_hiPSC-NPC2

value: D


title: Sample_119_1_hiPSC-NPC2


title: Sample_120_3B_hiPSC-NPC2


title: Sample_120_3_hiPSC-NPC2


title: Sample_134_2_hiPSC-NPC2

value: H


title: Sample_109_3_hiPSC-NPC2

value: C


title: Sample_6_1_3_6w_hiPSC-neurons

value: hiPSC-neurons (mixed forebrain neurons)


title: Sample_105_1B_hiPSC-NPC3

value: hiPSC-NPCs (neural progenitor cells)


title: Sample_105_1_hiPSC-NPC1


title: Sample_105_1_hiPSC-NPC3


title: Sample_6_2_10_8w_hiPSC-neurons


title: Sample_106_4_hiPSC-NPC3

value: M


title: Sample_6_1_3_4w_hiPSC-neurons

value: CTRL


title: Sample_6_1_11_6w_hiPSC-neurons


title: Sample_105_5_hiPSC-NPC3


title: Sample_6_1_11_4w_hiPSC-neurons


title: Sample_263_3_4w_hiPSC-neurons


title: Sample_6_2_10_6w_hiPSC-neurons


title: Sample_105_2_hiPSC-NPC1


title: Sample_109_1_hiPSC-NPC3


title: Sample_262_3_8w_hiPSC-neurons

value: J


title: Sample_262_3_6w_hiPSC-neurons

value: F


title: Sample_262_6_6w_hiPSC-neurons


title: Sample_106_4_hiPSC-NPC1

value: PMS


title: Sample_262_3_4w_hiPSC-neurons


title: Sample_263_3_N1_4w_hiPSC-neurons


title: Sample_188_3_8w_hiPSC-neurons


title: Sample_188_3_4w_hiPSC-neurons


title: Sample_188_3_6w_hiPSC-neurons


title: Sample_120_4_8w_hiPSC-neurons


title: Sample_106_4B_hiPSC-NPC1

value: B


title: Sample_120_4_6w_hiPSC-neurons


title: Sample_120_4_4w_hiPSC-neurons


title: Sample_120_3_N1_8w_hiPSC-neurons


title: Sample_120_3_N1_6w_hiPSC-neurons


title: Sample_120_3_N1_4w_hiPSC-neurons


title: Sample_120_3_8w_hiPSC-neurons


title: Sample_109_1_6w_hiPSC-neurons


title: Sample_119_1_6w_hiPSC-neurons


title: Sample_119_1_4w_hiPSC-neurons


title: Sample_109_3_6w_hiPSC-neurons


title: Sample_119_1_8w_hiPSC-neurons


title: Sample_105_1B_6w_hiPSC-neurons


title: Sample_109_3_4w_hiPSC-neurons


title: Sample_106_4_8w_hiPSC-neurons


title: Sample_106_4_6w_hiPSC-neurons


title: Sample_262_6_4w_hiPSC-neurons


title: Sample_105_1B_4w_hiPSC-neurons


title: Sample_109_1_4w_hiPSC-neurons


title: Sample_105_1_8w_hiPSC-neurons


title: Sample_105_1_6w_hiPSC-neurons


title: undiff_TLR9-OE_sgIRF7-2_ns_1

city: Vienna

first: Vitaly

last: Sedlyarov

address: Lazarettgasse 14, AKH BT 25.3

country: Austria

institute: Research Center for Molecular Medicine

data_processing:
basecalling: Illumina2bam, version 1.17
adapter and quality trimming: cutadapt, version 1.16
mapping: STAR, version 2.5.2b
quantification: ESAT
Genome_build: hg38

source_name: THP-1 (TLR9-overexpression) cell line

growth_protocol: THP-1 cells were purchased from ATCC. Cells were grown in RPMI supplemented with 10% (v/v) FBS and antibiotics (100 U/ml penicillin, 100 mg/ml streptomycin), all from Gibco. Cells were incubated at 37°C in 5% CO2.

extract_protocol:
RNA was isolated using the QIAGEN RNeasy Mini kit including a DNase I digest step.
RNA-Seq libraries were prepared using QuantSeq 3’ mRNA-Seq Library Prep Kit FWD for Illumina (Lexogen) according to the manufacture’s protocol.

treatment_protocol: THP1 control (sgRen) and two SLC15A4- and CXorf21-deficient cell lines (3E6 cells per point) were left untreated or stimulated for 6 hours with 5 μg/ml R848.

tag: sgrna

value: untreated


title: undiff_TLR9-OE_sgIRF7-2_CpG_1

value: CpG


title: undiff_TLR9-OE_sgIRF7-2_ns_2


title: undiff_TLR9-OE_sgIRF7-2_CpG_3


title: undiff_TLR9-OE_sgIRF7-2_CpG_2


title: undiff_TLR9-OE_sgIRF7-1_CpG_1


title: Sample_105_1_4w_hiPSC-neurons


title: undiff_TLR9-OE_sgIRF7-1_CpG_2


title: Sample_120_3_6w_hiPSC-neurons

value: G


title: Sample_120_3_4w_hiPSC-neurons


title: Sample_109_1_8w_hiPSC-neurons


title: Sample_105_1B_8w_hiPSC-neurons


title: undiff_TLR9-OE_sgIRF7-1_ns_3


title: undiff_TLR9-OE_sgIRF7-1_ns_2


title: undiff_TLR9-OE_sgIRF5-2_CpG_2


title: undiff_TLR9-OE_sgIRF7-2_ns_3


title: undiff_TLR9-OE_sgIRF5-2_ns_3


title: undiff_TLR9-OE_sgIRF5-2_CpG_1


title: undiff_TLR9-OE_sgIRF5-2_ns_2


title: undiff_TLR9-OE_sgIRF5-2_CpG_3


title: undiff_TLR9-OE_sgIRF5-1_CpG_1


title: undiff_TLR9-OE_sgIRF5-1_ns_3


title: undiff_TLR9-OE_sgIRF7-1_ns_1


title: undiff_TLR9-OE_sgIRF5-1_ns_2


title: undiff_TLR9-OE_sgIRF5-1_CpG_3


title: undiff_TLR9-OE_sgIRF3-2_CpG_3


title: undiff_TLR9-OE_sgIRF5-2_ns_1


title: undiff_TLR9-OE_sgIRF5-1_CpG_2


title: undiff_TLR9-OE_sgIRF7-1_CpG_3


title: undiff_TLR9-OE_sgIRF3-2_CpG_2


title: undiff_TLR9-OE_sgIRF3-2_ns_2


title: undiff_TLR9-OE_sgIRF3-2_ns_1


title: undiff_TLR9-OE_sgIRF3-2_CpG_1


title: undiff_TLR9-OE_sgIRF3-1_CpG_3


title: undiff_TLR9-OE_sgIRF3-1_CpG_2


title: undiff_TLR9-OE_sgIRF3-1_CpG_1


title: undiff_TLR9-OE_sgIRF3-1_ns_3


title: undiff_TLR9-OE_sgIRF3-1_ns_2


title: undiff_TLR9-OE_sgIRF3-1_ns_1


title: undiff_TLR9-OE_sgCX-5_CpG_3


title: undiff_TLR9-OE_sgCX-5_CpG_2


title: undiff_TLR9-OE_sgIRF5-1_ns_1


title: undiff_TLR9-OE_sgCX-5_ns_3


title: undiff_TLR9-OE_sgCX-5_ns_1


title: undiff_TLR9-OE_sgIRF3-2_ns_3


title: undiff_TLR9-OE_sgCX-1_CpG_3


title: undiff_TLR9-OE_sgSLC15A4-5_CpG_1


title: undiff_TLR9-OE_sgCX-1_ns_3


title: undiff_TLR9-OE_sgCX-1_ns_2


title: undiff_TLR9-OE_sgSLC15A4-5_ns_2


title: undiff_TLR9-OE_sgCX-5_ns_2


title: undiff_TLR9-OE_sgSLC15A4-5_ns_1


title: undiff_TLR9-OE_sgSLC15A4-2_CpG_2


title: undiff_TLR9-OE_sgSLC15A4-2_CpG_1


title: undiff_TLR9-OE_sgCX-1_ns_1


title: undiff_TLR9-OE_sgSLC15A4-2_ns_3


title: undiff_TLR9-OE_sgSLC15A4-2_CpG_3


title: undiff_TLR9-OE_sgCX-1_CpG_1


title: undiff_TLR9-OE_sgSLC15A4-2_ns_2


title: undiff_TLR9-OE_sgRen_CpG_3

value: sgRen


title: undiff_TLR9-OE_sgSLC15A4-2_ns_1


title: undiff_TLR9-OE_sgRen_CpG_1


title: undiff_TLR9-OE_sgRen_CpG_2


title: undiff_TLR9-OE_sgRen_ns_3


title: undiff_TLR9-OE_sgCX-5_CpG_1


title: undiff_TLR9-OE_sgRen_ns_2


title: undiff_TLR9-OE_sgCX-1_CpG_2


title: undiff_TLR9-OE_sgSLC15A4-5_CpG_2


title: undiff_TLR9-OE_sgSLC15A4-5_CpG_3


title: undiff_TLR9-OE_sgSLC15A4-5_ns_3


title: E SOR Rep 2 [SOR_E_71_9_5_I2]

first: Ravi

last: Iyengar

address: 1425 Madison Avenue, Room 12-70C

department: Pharmacological Sciences

institute: Icahn School of Medicine at Mount Sinai

description:
RNAseq_20161108.I2
Sample SOR_E_71_9_5_I2

data_processing:
Data preparation and analysis workflow for 3'-DGE mRNA-seq dataset: https://github.com/DToxS/DGE-GEO-Depot
Aligning 3'-DGE mRNA sequence reads: https://github.com/DToxS/Sequence-Alignment
Mapping aligned 3'-DGE sequence reads to reference genes: https://github.com/DToxS/Feature-Counts
Identifying differentially expressed genes for 3'-DGE mRNA-seq dataset: https://github.com/DToxS/Differential-Comparison
Genome_build: Reference-Library.tar.gz: a compressed file containing the UCSC human genome referece library (version hg38)
Supplementary_files_format_and_content:
DGE-RNAseq-Experiment-Design-20150409.tsv.gz: a compressed file containing the experiment design table of all the samples from the 20150409 dataset to be used by the DEG-comparison pipeline
DGE-RNAseq-Read-Counts-20150409.tsv.gz: a compressed file containing the read counts table of the uniquely aligned sequence fragments for the 20150409 dataset
Differential-Comparison-Configs-20150409.tar.gz: a compressed file containing the configuration of the DEG-comparison pipeline file for the 20150409 dataset
Differential-Comparison-Params-20150409.tar.gz: a compressed file containing the input parameter files of the DEG-comparison pipeline file for the 20150409 dataset
DEG-Calc-FDR-0.1-20150409.tar.gz: a compressed file containing a set of statistical comparison results of differentially expressed genes at each drug-treated condition with the file names in a form of Human-[Cell Line]-Hour-48-Plate-[Plate Number]-Calc.CTRL-[Drug Name].tsv for the 20150409 dataset
DGE-RNAseq-Experiment-Design-20150503.tsv.gz: a compressed file containing the experiment design table of all the samples from the 20150503 dataset to be used by the DEG-comparison pipeline
DGE-RNAseq-Read-Counts-20150503.tsv.gz: a compressed file containing the read counts table of the uniquely aligned sequence fragments for the 20150503 dataset
Differential-Comparison-Configs-20150503.tar.gz: a compressed file containing the configuration of the DEG-comparison pipeline file for the 20150503 dataset
Differential-Comparison-Params-20150503.tar.gz: a compressed file containing the input parameter files of the DEG-comparison pipeline file for the 20150503 dataset
DGE-RNAseq-Experiment-Design-20151120.tsv.gz: a compressed file containing the experiment design table of all the samples from the 20151120 dataset to be used by the DEG-comparison pipeline
DGE-RNAseq-Read-Counts-20151120.tsv.gz: a compressed file containing the read counts table of the uniquely aligned sequence fragments for the 20151120 dataset
Differential-Comparison-Configs-20151120.tar.gz: a compressed file containing the configuration of the DEG-comparison pipeline file for the 20151120 dataset
Differential-Comparison-Params-20151120.tar.gz: a compressed file containing the input parameter files of the DEG-comparison pipeline file for the 20151120 dataset
DEG-Calc-FDR-0.1-20151120.tar.gz: a compressed file containing a set of statistical comparison results of differentially expressed genes at each drug-treated condition with the file names in a form of Human-[Cell Line]-Hour-48-Plate-[Plate Number]-Calc.CTRL-[Drug Name].tsv for the 20151120 dataset
DGE-RNAseq-Experiment-Design-20161108-Cor.tsv.gz: a compressed file containing the experiment design table of all the samples from the 20161108-Cor dataset to be used by the DEG-comparison pipeline
DGE-RNAseq-Read-Counts-20161108-Cor.tsv.gz: a compressed file containing the read counts table of the uniquely aligned sequence fragments for the 20161108-Cor dataset
Differential-Comparison-Configs-20161108-Cor.tar.gz: a compressed file containing the configuration of the DEG-comparison pipeline file for the 20161108-Cor dataset
Differential-Comparison-Params-20161108-Cor.tar.gz: a compressed file containing the input parameter files of the DEG-comparison pipeline file for the 20161108-Cor dataset
DEG-Calc-FDR-0.1-20161108-Cor.tar.gz: a compressed file containing a set of statistical comparison results of differentially expressed genes at each drug-treated condition with the file names in a form of Human-[Cell Line]-Hour-48-Plate-[Plate Number]-Calc.CTRL-[Drug Name].tsv for the 20161108-Cor dataset
DGE-RNAseq-Experiment-Design-20161108-Spec-Fixed.tsv.gz: a compressed file containing the experiment design table of all the samples from the 20161108-Spec-Fixed dataset to be used by the DEG-comparison pipeline
DGE-RNAseq-Read-Counts-20161108-Spec-Fixed.tsv.gz: a compressed file containing the read counts table of the uniquely aligned sequence fragments for the 20161108-Spec-Fixed dataset
Differential-Comparison-Configs-20161108-Spec-Fixed.tar.gz: a compressed file containing the configuration of the DEG-comparison pipeline file for the 20161108-Spec-Fixed dataset
Differential-Comparison-Params-20161108-Spec-Fixed.tar.gz: a compressed file containing the input parameter files of the DEG-comparison pipeline file for the 20161108-Spec-Fixed dataset
DEG-Calc-FDR-0.1-20161108-Spec-Fixed.tar.gz: a compressed file containing a set of statistical comparison results of differentially expressed genes at each drug-treated condition with the file names in a form of Human-[Cell Line]-Hour-48-Plate-[Plate Number]-Calc.CTRL-[Drug Name].tsv for the 20161108-Spec-Fixed dataset
DGE-RNAseq-Experiment-Design-20161108-Spec-Var-1.tsv.gz: a compressed file containing the experiment design table of all the samples from the 20161108-Spec-Var-1 dataset to be used by the DEG-comparison pipeline
DGE-RNAseq-Read-Counts-20161108-Spec-Var-1.tsv.gz: a compressed file containing the read counts table of the uniquely aligned sequence fragments for the 20161108-Spec-Var-1 dataset
Differential-Comparison-Configs-20161108-Spec-Var-1.tar.gz: a compressed file containing the configuration of the DEG-comparison pipeline file for the 20161108-Spec-Var-1 dataset
Differential-Comparison-Params-20161108-Spec-Var-1.tar.gz: a compressed file containing the input parameter files of the DEG-comparison pipeline file for the 20161108-Spec-Var-1 dataset
DEG-Calc-FDR-0.1-20161108-Spec-Var-1.tar.gz: a compressed file containing a set of statistical comparison results of differentially expressed genes at each drug-treated condition with the file names in a form of Human-[Cell Line]-Hour-48-Plate-[Plate Number]-Calc.CTRL-[Drug Name].tsv for the 20161108-Spec-Var-1 dataset
DGE-RNAseq-Experiment-Design-20161108-Spec-Var-2.tsv.gz: a compressed file containing the experiment design table of all the samples from the 20161108-Spec-Var-2 dataset to be used by the DEG-comparison pipeline
DGE-RNAseq-Read-Counts-20161108-Spec-Var-2.tsv.gz: a compressed file containing the read counts table of the uniquely aligned sequence fragments for the 20161108-Spec-Var-2 dataset
Differential-Comparison-Configs-20161108-Spec-Var-2.tar.gz: a compressed file containing the configuration of the DEG-comparison pipeline file for the 20161108-Spec-Var-2 dataset
Differential-Comparison-Params-20161108-Spec-Var-2.tar.gz: a compressed file containing the input parameter files of the DEG-comparison pipeline file for the 20161108-Spec-Var-2 dataset
DEG-Calc-FDR-0.1-20161108-Spec-Var-2.tar.gz: a compressed file containing a set of statistical comparison results of differentially expressed genes at each drug-treated condition with the file names in a form of Human-[Cell Line]-Hour-48-Plate-[Plate Number]-Calc.CTRL-[Drug Name].tsv for the 20161108-Spec-Var-2 dataset
DGE-RNAseq-Experiment-Design-20161108-Spec-Var-3.tsv.gz: a compressed file containing the experiment design table of all the samples from the 20161108-Spec-Var-3 dataset to be used by the DEG-comparison pipeline
DGE-RNAseq-Read-Counts-20161108-Spec-Var-3.tsv.gz: a compressed file containing the read counts table of the uniquely aligned sequence fragments for the 20161108-Spec-Var-3 dataset
Differential-Comparison-Configs-20161108-Spec-Var-3.tar.gz: a compressed file containing the configuration of the DEG-comparison pipeline file for the 20161108-Spec-Var-3 dataset
Differential-Comparison-Params-20161108-Spec-Var-3.tar.gz: a compressed file containing the input parameter files of the DEG-comparison pipeline file for the 20161108-Spec-Var-3 dataset
DEG-Calc-FDR-0.1-20161108-Spec-Var-3.tar.gz: a compressed file containing a set of statistical comparison results of differentially expressed genes at each drug-treated condition with the file names in a form of Human-[Cell Line]-Hour-48-Plate-[Plate Number]-Calc.CTRL-[Drug Name].tsv for the 20161108-Spec-Var-3 dataset
Program-Source-Codes.tar.gz: a compressed file containing the source codes for sequence alignment, feature counts, and differential comparison.

source_name: primary cardiomyocytes_Sorafenib

growth_protocol: Cultured under growth conditions with antibiotic free growth media and differentiated for four weeks with antibiotic free differentiation media (see DToxS SOP CE – 1.0: PromoCell Cardiomyocyte Subculture, DToxS SOP CE – 2.0: PromoCell Cardiomyocyte Plating for Drug Test)

extract_protocol:
Total RNA was isolated using Trizol (see DToxS SOP A – 1.0: Total RNA Isolation)
Using the sample name scheme [Treatment Condition]_[Cell Line]_[Investigative Unit]_[Sample ID]_[Plate Number]_[Well Number], library was prepared using 150ng (for the samples with the plate number 1 and 2) and 200ng (for the samples with the plate number 4 and 5) of total RNA enriched for mRNA using polyA beads and the TruSeq RNA Library Prep Kit (Illumina, Cat: RS-122-2001) per manufacturer’s instructions

treatment_protocol: Fully confluent and differentiated cells were treated with drugs or vehicle (DMSO) for 48 hours (see DToxS SOP CE – 4.0: Drug Treatment and Cell Lysis)

tag: source organ

value: Heart

value: cardiac myocytes

tag: treatment condition

value: Sorafenib

tag: concentration

tag: treatment time (hrs)

tag: vendor

value: PromoCell

tag: cat #

tag: lot #

tag: well

tag: investigative unit

tag: sample id

tag: rna amount (ng)

tag: nanodrop 260/280

tag: rna conc (ng/ul)

tag: rna volume (ul)

tag: h2o volume (ul)


title: E SOR Rep 1 [SOR_E_52_8_5_E2]

description:
RNAseq_20161108.E2
Sample SOR_E_52_8_5_E2

tag: cell type


title: E SOR Rep 3 [SOR_E_55_20_5_E15]

description:
RNAseq_20161108.E15
Sample SOR_E_55_20_5_E15


title: E SOR Rep 4 [SOR_E_73_8_5_I15]

description:
RNAseq_20161108.I15
Sample SOR_E_73_8_5_I15


title: E LAP Rep 3 [LAP_E_71_10_5_I3]

description:
RNAseq_20161108.I3
Sample LAP_E_71_10_5_I3

source_name: primary cardiomyocytes_Lapatinib

value: Lapatinib


title: E LAP Rep 4 [LAP_E_73_9_5_I16]

description:
RNAseq_20161108.I16
Sample LAP_E_73_9_5_I16


title: E CTRL Rep 4 [CTRL_E_71_1_5_H21]

description:
RNAseq_20161108.H21
Sample CTRL_E_71_1_5_H21

source_name: primary cardiomyocytes_Vehicle Control

value: Vehicle Control


title: E LAP Rep 1 [LAP_E_43_18_5_D1]

description:
RNAseq_20161108.D1
Sample LAP_E_43_18_5_D1


title: E CTRL Rep 7 [CTRL_E_86_1_5_N5]

description:
RNAseq_20161108.N5
Sample CTRL_E_86_1_5_N5


title: E CTRL Rep 8 [CTRL_E_92_1_5_P11]

description:
RNAseq_20161108.P11
Sample CTRL_E_92_1_5_P11


title: E CTRL Rep 3 [CTRL_E_69_1_5_P9]

description:
RNAseq_20161108.P9
Sample CTRL_E_69_1_5_P9


title: E CTRL Rep 5 [CTRL_E_73_1_5_I10]

description:
RNAseq_20161108.I10
Sample CTRL_E_73_1_5_I10


title: E LAP Rep 2 [LAP_E_47_6_5_D9]

description:
RNAseq_20161108.D9
Sample LAP_E_47_6_5_D9


title: E CTRL Rep 6 [CTRL_E_85_1_5_M21]

description:
RNAseq_20161108.M21
Sample CTRL_E_85_1_5_M21


title: E CTRL Rep 1 [CTRL_E_36_2_5_C5]

description:
RNAseq_20161108.C5
Sample CTRL_E_36_2_5_C5


title: D REG Rep 4 [REG_D_70_6_5_H19]

description:
RNAseq_20161108.H19
Sample REG_D_70_6_5_H19

source_name: primary cardiomyocytes_Regorafenib

value: Regorafenib


title: D REG Rep 3 [REG_D_42_13_5_C23]

description:
RNAseq_20161108.C23
Sample REG_D_42_13_5_C23


title: D REG Rep 2 [REG_D_39_30_5_C21]

description:
RNAseq_20161108.C21
Sample REG_D_39_30_5_C21


title: E CTRL Rep 2 [CTRL_E_66_1_5_G16]

description:
RNAseq_20161108.G16
Sample CTRL_E_66_1_5_G16


title: undiff_TLR9-OE_sgRen_ns_1

tag: sgrna

tag: treatment


title: D REG Rep 1 [REG_D_30_26_5_B21]

description:
RNAseq_20161108.B21
Sample REG_D_30_26_5_B21

tag: source organ

tag: treatment condition


title: D LAP Rep 4 [LAP_D_96_5_5_P8]

description:
RNAseq_20161108.P8
Sample LAP_D_96_5_5_P8

tag: concentration

tag: treatment time (hrs)


title: D LAP Rep 3 [LAP_D_96_4_5_P7]

description:
RNAseq_20161108.P7
Sample LAP_D_96_4_5_P7

tag: vendor

tag: cat #


title: D LAP Rep 1 [LAP_D_42_22_5_C24]

description:
RNAseq_20161108.C24
Sample LAP_D_42_22_5_C24

tag: lot #

tag: well


title: D LAP Rep 2 [LAP_D_94_7_5_P1]

description:
RNAseq_20161108.P1
Sample LAP_D_94_7_5_P1

tag: investigative unit

tag: sample id


title: D CTRL Rep 8 [CTRL_D_94_1_5_O21]

description:
RNAseq_20161108.O21
Sample CTRL_D_94_1_5_O21

tag: rna amount (ng)

tag: nanodrop 260/280


title: D CTRL Rep 7 [CTRL_D_83_1_5_P10]

description:
RNAseq_20161108.P10
Sample CTRL_D_83_1_5_P10

tag: rna conc (ng/ul)

tag: rna volume (ul)


title: D CTRL Rep 6 [CTRL_D_80_1_5_K24]

description:
RNAseq_20161108.K24
Sample CTRL_D_80_1_5_K24

tag: cell type

tag: h2o volume (ul)


title: D CTRL Rep 5 [CTRL_D_78_1_5_K7]

description:
RNAseq_20161108.K7
Sample CTRL_D_78_1_5_K7


title: D CTRL Rep 4 [CTRL_D_70_1_5_H14]

description:
RNAseq_20161108.H14
Sample CTRL_D_70_1_5_H14


title: D CTRL Rep 2 [CTRL_D_63_1_5_F23]

description:
RNAseq_20161108.F23
Sample CTRL_D_63_1_5_F23


title: D CTRL Rep 3 [CTRL_D_65_1_5_G10]

description:
RNAseq_20161108.G10
Sample CTRL_D_65_1_5_G10


title: B TOF Rep 4 [TOF_B_46_9_5_D8]

description:
RNAseq_20161108.D8
Sample TOF_B_46_9_5_D8

source_name: primary cardiomyocytes_Tofacitinib

value: Tofacitinib


title: B VAN Rep 3 [VAN_B_40_7_5_C22]

description:
RNAseq_20161108.C22
Sample VAN_B_40_7_5_C22

source_name: primary cardiomyocytes_Vandetanib

value: Vandetanib


title: B VAN Rep 4 [VAN_B_44_10_5_D6]

description:
RNAseq_20161108.D6
Sample VAN_B_44_10_5_D6


title: B VAN Rep 2 [VAN_B_23_20_5_B11]

description:
RNAseq_20161108.B11
Sample VAN_B_23_20_5_B11


title: B TOF Rep 2 [TOF_B_23_3_5_B8]

description:
RNAseq_20161108.B8
Sample TOF_B_23_3_5_B8


title: B SUN Rep 2 [SUN_B_12_20_5_A5]

description:
RNAseq_20161108.A5
Sample SUN_B_12_20_5_A5

source_name: primary cardiomyocytes_Sunitinib

value: Sunitinib


title: B SUN Rep 3 [SUN_B_17_13_5_A8]

description:
RNAseq_20161108.A8
Sample SUN_B_17_13_5_A8


title: B TOF Rep 1 [TOF_B_21_21_5_A21]

description:
RNAseq_20161108.A21
Sample TOF_B_21_21_5_A21


title: B SOR Rep 1 [SOR_B_21_2_5_A19]

description:
RNAseq_20161108.A19
Sample SOR_B_21_2_5_A19


title: B SOR Rep 3 [SOR_B_67_15_5_H3]

description:
RNAseq_20161108.H3
Sample SOR_B_67_15_5_H3


title: B LAP Rep 4 [LAP_B_100_7_5_P15]

description:
RNAseq_20161108.P15
Sample LAP_B_100_7_5_P15


title: B SOR Rep 4 [SOR_B_72_15_5_I9]

description:
RNAseq_20161108.I9
Sample SOR_B_72_15_5_I9


title: B SUN Rep 1 [SUN_B_12_19_5_A4]

description:
RNAseq_20161108.A4
Sample SUN_B_12_19_5_A4


title: B SUN Rep 4 [SUN_B_33_13_5_C1]

description:
RNAseq_20161108.C1
Sample SUN_B_33_13_5_C1


title: B CTRL Rep 7 [CTRL_B_84_1_5_M12]

description:
RNAseq_20161108.M12
Sample CTRL_B_84_1_5_M12


title: B LAP Rep 3 [LAP_B_95_7_5_P4]

description:
RNAseq_20161108.P4
Sample LAP_B_95_7_5_P4


title: B LAP Rep 1 [LAP_B_18_4_5_A9]

description:
RNAseq_20161108.A9
Sample LAP_B_18_4_5_A9


title: B CTRL Rep 8 [CTRL_B_95_1_5_P12]

description:
RNAseq_20161108.P12
Sample CTRL_B_95_1_5_P12


title: B LAP Rep 2 [LAP_B_44_6_5_D3]

description:
RNAseq_20161108.D3
Sample LAP_B_44_6_5_D3


title: B TOF Rep 3 [TOF_B_44_8_5_D4]

description:
RNAseq_20161108.D4
Sample TOF_B_44_8_5_D4


title: B CTRL Rep 4 [CTRL_B_67_1_5_G21]

description:
RNAseq_20161108.G21
Sample CTRL_B_67_1_5_G21


title: D CTRL Rep 1 [CTRL_D_48_1_5_D11]

description:
RNAseq_20161108.D11
Sample CTRL_D_48_1_5_D11


title: B CTRL Rep 6 [CTRL_B_82_1_5_L18]

description:
RNAseq_20161108.L18
Sample CTRL_B_82_1_5_L18


title: B VAN Rep 1 [VAN_B_21_25_5_A22]

description:
RNAseq_20161108.A22
Sample VAN_B_21_25_5_A22


title: B CTRL Rep 3 [CTRL_B_64_1_5_G5]

description:
RNAseq_20161108.G5
Sample CTRL_B_64_1_5_G5


title: B CTRL Rep 5 [CTRL_B_74_1_5_I18]

description:
RNAseq_20161108.I18
Sample CTRL_B_74_1_5_I18


title: B CTRL Rep 1 [CTRL_B_18_1_5_J21]

description:
RNAseq_20161108.J21
Sample CTRL_B_18_1_5_J21


title: B SOR Rep 2 [SOR_B_53_20_5_E8]

description:
RNAseq_20161108.E8
Sample SOR_B_53_20_5_E8


title: B BOS Rep 3 [BOS_B_33_24_5_C2]

description:
RNAseq_20161108.C2
Sample BOS_B_33_24_5_C2

source_name: primary cardiomyocytes_Bosutinib

value: Bosutinib


title: B BOS Rep 2 [BOS_B_23_7_5_B9]

description:
RNAseq_20161108.B9
Sample BOS_B_23_7_5_B9


title: B BOS Rep 1 [BOS_B_21_16_5_A20]

description:
RNAseq_20161108.A20
Sample BOS_B_21_16_5_A20


title: A VEM Rep 2 [VEM_A_58_3_5_E19]

description:
RNAseq_20161108.E19
Sample VEM_A_58_3_5_E19

source_name: primary cardiomyocytes_Vemurafenib

value: Vemurafenib


title: A VEM Rep 4 [VEM_A_62_3_5_F15]

description:
RNAseq_20161108.F15
Sample VEM_A_62_3_5_F15


title: A VEM Rep 3 [VEM_A_61_3_5_F10]

description:
RNAseq_20161108.F10
Sample VEM_A_61_3_5_F10


title: B CTRL Rep 2 [CTRL_B_44_1_5_D2]

description:
RNAseq_20161108.D2
Sample CTRL_B_44_1_5_D2


title: B BOS Rep 4 [BOS_B_44_9_5_D5]

description:
RNAseq_20161108.D5
Sample BOS_B_44_9_5_D5


title: A TRA Rep 2 [TRA_A_49_17_5_D21]

description:
RNAseq_20161108.D21
Sample TRA_A_49_17_5_D21

source_name: primary cardiomyocytes_Trametinib

value: Trametinib


title: A VAN Rep 4 [VAN_A_38_5_5_C10]

description:
RNAseq_20161108.C10
Sample VAN_A_38_5_5_C10


title: A RUX Rep 3 [RUX_A_24_22_5_B17]

description:
RNAseq_20161108.B17
Sample RUX_A_24_22_5_B17

source_name: primary cardiomyocytes_Ruxolitinib

value: Ruxolitinib


title: A VAN Rep 1 [VAN_A_20_12_5_A14]

description:
RNAseq_20161108.A14
Sample VAN_A_20_12_5_A14


title: A RUX Rep 1 [RUX_A_20_16_5_A16]

description:
RNAseq_20161108.A16
Sample RUX_A_20_16_5_A16


title: A RUX Rep 4 [RUX_A_38_9_5_C12]

description:
RNAseq_20161108.C12
Sample RUX_A_38_9_5_C12


title: A VAN Rep 2 [VAN_A_22_15_5_B3]

description:
RNAseq_20161108.B3
Sample VAN_A_22_15_5_B3


title: A VEM Rep 1 [VEM_A_57_19_5_E16]

description:
RNAseq_20161108.E16
Sample VEM_A_57_19_5_E16


title: A TRA Rep 3 [TRA_A_54_3_5_E9]

description:
RNAseq_20161108.E9
Sample TRA_A_54_3_5_E9


title: A RUX Rep 2 [RUX_A_22_19_5_B5]

description:
RNAseq_20161108.B5
Sample RUX_A_22_19_5_B5


title: A PON Rep 2 [PON_A_38_14_5_C17]

description:
RNAseq_20161108.C17
Sample PON_A_38_14_5_C17

source_name: primary cardiomyocytes_Ponatinib

value: Ponatinib


title: A VAN Rep 3 [VAN_A_24_18_5_B15]

description:
RNAseq_20161108.B15
Sample VAN_A_24_18_5_B15


title: A REG Rep 4 [REG_A_54_9_5_E11]

description:
RNAseq_20161108.E11
Sample REG_A_54_9_5_E11


title: A TRA Rep 1 [TRA_A_38_21_5_C20]

description:
RNAseq_20161108.C20
Sample TRA_A_38_21_5_C20


title: A REG Rep 3 [REG_A_38_12_5_C15]

description:
RNAseq_20161108.C15
Sample REG_A_38_12_5_C15


title: A TRA Rep 4 [TRA_A_62_20_5_F22]

description:
RNAseq_20161108.F22
Sample TRA_A_62_20_5_F22


title: A PON Rep 3 [PON_A_49_10_5_D18]

description:
RNAseq_20161108.D18
Sample PON_A_49_10_5_D18


title: A REG Rep 1 [REG_A_38_11_5_C14]

description:
RNAseq_20161108.C14
Sample REG_A_38_11_5_C14


title: A PON Rep 1 [PON_A_38_13_5_C16]

description:
RNAseq_20161108.C16
Sample PON_A_38_13_5_C16


title: A PAZ Rep 4 [PAZ_A_49_8_5_D16]

description:
RNAseq_20161108.D16
Sample PAZ_A_49_8_5_D16

source_name: primary cardiomyocytes_Pazopanib

value: Pazopanib


title: A PON Rep 4 [PON_A_54_11_5_E12]

description:
RNAseq_20161108.E12
Sample PON_A_54_11_5_E12


title: A PAZ Rep 3 [PAZ_A_24_21_5_B16]

description:
RNAseq_20161108.B16
Sample PAZ_A_24_21_5_B16


title: A LAP Rep 4 [LAP_A_54_5_5_E10]

description:
RNAseq_20161108.E10
Sample LAP_A_54_5_5_E10


title: A REG Rep 2 [REG_A_49_9_5_D17]

description:
RNAseq_20161108.D17
Sample REG_A_49_9_5_D17


title: A PAZ Rep 2 [PAZ_A_22_18_5_B4]

description:
RNAseq_20161108.B4
Sample PAZ_A_22_18_5_B4


title: A PAZ Rep 1 [PAZ_A_20_15_5_A15]

description:
RNAseq_20161108.A15
Sample PAZ_A_20_15_5_A15


title: A LAP Rep 3 [LAP_A_22_22_5_B7]

description:
RNAseq_20161108.B7
Sample LAP_A_22_22_5_B7


title: A LAP Rep 2 [LAP_A_106_6_5_P24]

description:
RNAseq_20161108.P24
Sample LAP_A_106_6_5_P24


title: A ERL Rep 1 [ERL_A_20_6_5_A12]

description:
RNAseq_20161108.A12
Sample ERL_A_20_6_5_A12

source_name: primary cardiomyocytes_Erlotinib

value: Erlotinib


title: A ERL Rep 2 [ERL_A_22_6_5_B1]

description:
RNAseq_20161108.B1
Sample ERL_A_22_6_5_B1

value: Heart


title: A DAS Rep 4 [DAS_A_102_4_5_P18]

description:
RNAseq_20161108.P18
Sample DAS_A_102_4_5_P18

source_name: primary cardiomyocytes_Dasatinib

value: cardiac myocytes

value: Dasatinib


title: A CTRL Rep 7 [CTRL_A_87_1_5_N14]

description:
RNAseq_20161108.N14
Sample CTRL_A_87_1_5_N14

value: PromoCell


title: A CTRL Rep 4 [CTRL_A_61_1_5_F9]

description:
RNAseq_20161108.F9
Sample CTRL_A_61_1_5_F9


title: A CTRL Rep 3 [CTRL_A_38_1_5_C8]

description:
RNAseq_20161108.C8
Sample CTRL_A_38_1_5_C8


title: A LAP Rep 1 [LAP_A_102_8_5_P19]

description:
RNAseq_20161108.P19
Sample LAP_A_102_8_5_P19

value: Lapatinib


title: A CTRL Rep 9 [CTRL_A_93_1_5_O17]

description:
RNAseq_20161108.O17
Sample CTRL_A_93_1_5_O17

value: Vehicle Control


title: A CTRL Rep 6 [CTRL_A_79_1_5_K15]

description:
RNAseq_20161108.K15
Sample CTRL_A_79_1_5_K15


title: A CER Rep 1 [CER_A_38_8_5_C11]

description:
RNAseq_20161108.C11
Sample CER_A_38_8_5_C11

source_name: primary cardiomyocytes_Ceritinib

value: Ceritinib


title: A CTRL Rep 8 [CTRL_A_88_1_5_N23]

description:
RNAseq_20161108.N23
Sample CTRL_A_88_1_5_N23


title: A DAS Rep 2 [DAS_A_49_3_5_D15]

description:
RNAseq_20161108.D15
Sample DAS_A_49_3_5_D15


title: A ERL Rep 3 [ERL_A_24_8_5_B13]

description:
RNAseq_20161108.B13
Sample ERL_A_24_8_5_B13


title: A CTRL Rep 10 [CTRL_A_102_1_5_P16]

description:
RNAseq_20161108.P16
Sample CTRL_A_102_1_5_P16


title: A CTRL Rep 2 [CTRL_A_22_1_5_A23]

description:
RNAseq_20161108.A23
Sample CTRL_A_22_1_5_A23


title: A CER Rep 4 [CER_A_62_19_5_F21]

description:
RNAseq_20161108.F21
Sample CER_A_62_19_5_F21


title: A CAB Rep 1 [CAB_A_49_16_5_D20]

description:
RNAseq_20161108.D20
Sample CAB_A_49_16_5_D20

source_name: primary cardiomyocytes_Cabozantinib

value: Cabozantinib


title: A CTRL Rep 5 [CTRL_A_76_1_5_J12]

description:
RNAseq_20161108.J12
Sample CTRL_A_76_1_5_J12


title: A CER Rep 3 [CER_A_57_22_5_E18]

description:
RNAseq_20161108.E18
Sample CER_A_57_22_5_E18


title: A CAB Rep 2 [CAB_A_57_21_5_E17]

description:
RNAseq_20161108.E17
Sample CAB_A_57_21_5_E17


title: A CER Rep 2 [CER_A_49_18_5_D22]

description:
RNAseq_20161108.D22
Sample CER_A_49_18_5_D22


title: A DAS Rep 1 [DAS_A_20_20_5_A18]

description:
RNAseq_20161108.A18
Sample DAS_A_20_20_5_A18


title: A AFA Rep 4 [AFA_A_38_10_5_C13]

description:
RNAseq_20161108.C13
Sample AFA_A_38_10_5_C13

source_name: primary cardiomyocytes_Afatinib

value: Afatinib


title: A BOS Rep 4 [BOS_A_38_4_5_C9]

description:
RNAseq_20161108.C9
Sample BOS_A_38_4_5_C9


title: A CTRL Rep 1 [CTRL_A_MC_1_5_A1]

description:
RNAseq_20161108.A1
Sample CTRL_A_MC_1_5_A1


title: A BOS Rep 3 [BOS_A_24_17_5_B14]

description:
RNAseq_20161108.B14
Sample BOS_A_24_17_5_B14


title: A BOS Rep 1 [BOS_A_20_11_5_A13]

description:
RNAseq_20161108.A13
Sample BOS_A_20_11_5_A13


title: A BOS Rep 2 [BOS_A_22_14_5_B2]

description:
RNAseq_20161108.B2
Sample BOS_A_22_14_5_B2


title: A AFA Rep 1 [AFA_A_20_17_5_A17]

description:
RNAseq_20161108.A17
Sample AFA_A_20_17_5_A17


title: E VEM Rep 4 [VEM_E_47_21_4_O5]

description:
RNAseq_20151120.O5
Sample VEM_E_47_21_4_O5


title: E VEM Rep 2 [VEM_E_41_21_4_J14]

description:
RNAseq_20151120.J14
Sample VEM_E_41_21_4_J14


title: E VEM Rep 1 [VEM_E_37_17_4_G9]

description:
RNAseq_20151120.G9
Sample VEM_E_37_17_4_G9


title: E VAN Rep 4 [VAN_E_43_5_4_L7]

description:
RNAseq_20151120.L7
Sample VAN_E_43_5_4_L7

value: Vandetanib


title: E TRA Rep 4 [TRA_E_47_23_4_O7]

description:
RNAseq_20151120.O7
Sample TRA_E_47_23_4_O7


title: E TRA Rep 1 [TRA_E_37_20_4_G11]

description:
RNAseq_20151120.G11
Sample TRA_E_37_20_4_G11


title: E TOF Rep 4 [TOF_E_37_3_4_F21]

description:
RNAseq_20151120.F21
Sample TOF_E_37_3_4_F21

value: Tofacitinib


title: E VAN Rep 2 [VAN_E_37_6_4_F24]

description:
RNAseq_20151120.F24
Sample VAN_E_37_6_4_F24


title: E VAN Rep 1 [VAN_E_36_10_4_F14]

description:
RNAseq_20151120.F14
Sample VAN_E_36_10_4_F14


title: E TRA Rep 2 [TRA_E_41_23_4_J16]

description:
RNAseq_20151120.J16
Sample TRA_E_41_23_4_J16


title: E TOF Rep 3 [TOF_E_36_7_4_F11]

description:
RNAseq_20151120.F11
Sample TOF_E_36_7_4_F11


title: A AFA Rep 3 [AFA_A_24_23_5_B18]

description:
RNAseq_20161108.B18
Sample AFA_A_24_23_5_B18


title: A AFA Rep 2 [AFA_A_22_20_5_B6]

description:
RNAseq_20161108.B6
Sample AFA_A_22_20_5_B6


title: E TOF Rep 1 [TOF_E_32_11_4_E18]

description:
RNAseq_20151120.E18
Sample TOF_E_32_11_4_E18


title: E TRA Rep 3 [TRA_E_43_16_4_L18]

description:
RNAseq_20151120.L18
Sample TRA_E_43_16_4_L18


title: E VEM Rep 3 [VEM_E_43_14_4_L16]

description:
RNAseq_20151120.L16
Sample VEM_E_43_14_4_L16

value: Vemurafenib


title: E SUN Rep 4 [SUN_E_47_4_4_N23]

description:
RNAseq_20151120.N23
Sample SUN_E_47_4_4_N23

value: Sunitinib


title: E SUN Rep 3 [SUN_E_45_8_4_M22]

description:
RNAseq_20151120.M22
Sample SUN_E_45_8_4_M22


title: E SUN Rep 1 [SUN_E_43_23_4_L23]

description:
RNAseq_20151120.L23
Sample SUN_E_43_23_4_L23


title: E SUN Rep 2 [SUN_E_45_7_4_M21]

description:
RNAseq_20151120.M21
Sample SUN_E_45_7_4_M21


title: E RUX Rep 3 [RUX_E_43_9_4_L11]

description:
RNAseq_20151120.L11
Sample RUX_E_43_9_4_L11

value: Ruxolitinib


title: E RUX Rep 4 [RUX_E_47_17_4_O2]

description:
RNAseq_20151120.O2
Sample RUX_E_47_17_4_O2


title: E VAN Rep 3 [VAN_E_41_8_4_J5]

description:
RNAseq_20151120.J5
Sample VAN_E_41_8_4_J5


title: E SOR Rep 3 [SOR_E_45_18_4_N1]

description:
RNAseq_20151120.N1
Sample SOR_E_45_18_4_N1

source_name: primary cardiomyocytes_Sorafenib

value: Sorafenib


title: E SOR Rep 2 [SOR_E_29_13_4_D16]

description:
RNAseq_20151120.D16
Sample SOR_E_29_13_4_D16


title: E SOR Rep 1 [SOR_E_27_12_4_D4]

description:
RNAseq_20151120.D4
Sample SOR_E_27_12_4_D4


title: E TOF Rep 2 [TOF_E_26_25_4_F5]

description:
RNAseq_20151120.F5
Sample TOF_E_26_25_4_F5


title: E RUX Rep 1 [RUX_E_37_10_4_G4]

description:
RNAseq_20151120.G4
Sample RUX_E_37_10_4_G4


title: E REG Rep 3 [REG_E_43_11_4_L13]

description:
RNAseq_20151120.L13
Sample REG_E_43_11_4_L13

value: Regorafenib


title: E RUX Rep 2 [RUX_E_41_12_4_J9]

description:
RNAseq_20151120.J9
Sample RUX_E_41_12_4_J9


title: E REG Rep 4 [REG_E_45_20_4_N2]

description:
RNAseq_20151120.N2
Sample REG_E_45_20_4_N2


title: E PON Rep 1 [PON_E_37_13_4_G7]

description:
RNAseq_20151120.G7
Sample PON_E_37_13_4_G7

value: Ponatinib


title: A DAS Rep 3 [DAS_A_93_4_5_O20]

description:
RNAseq_20161108.O20
Sample DAS_A_93_4_5_O20

value: Heart


title: E PAZ Rep 3 [PAZ_E_41_11_4_J8]

description:
RNAseq_20151120.J8
Sample PAZ_E_41_11_4_J8

value: cardiac myocytes

value: Pazopanib


title: E PAZ Rep 2 [PAZ_E_37_9_4_G3]

description:
RNAseq_20151120.G3
Sample PAZ_E_37_9_4_G3

value: PromoCell


title: E PAZ Rep 4 [PAZ_E_43_8_4_L10]

description:
RNAseq_20151120.L10
Sample PAZ_E_43_8_4_L10


title: E NIL Rep 4 [NIL_E_43_6_4_L8]

description:
RNAseq_20151120.L8
Sample NIL_E_43_6_4_L8

source_name: primary cardiomyocytes_Nilotinib

value: Nilotinib


title: E SOR Rep 4 [SOR_E_47_10_4_O1]

description:
RNAseq_20151120.O1
Sample SOR_E_47_10_4_O1


title: E NIL Rep 3 [NIL_E_41_9_4_J6]

description:
RNAseq_20151120.J6
Sample NIL_E_41_9_4_J6


title: E LAP Rep 2 [LAP_E_27_16_4_D5]

description:
RNAseq_20151120.D5
Sample LAP_E_27_16_4_D5

source_name: primary cardiomyocytes_Lapatinib

value: Lapatinib


title: E REG Rep 2 [REG_E_41_17_4_J11]

description:
RNAseq_20151120.J11
Sample REG_E_41_17_4_J11

source_name: primary cardiomyocytes_Regorafenib


title: E LAP Rep 3 [LAP_E_29_17_4_D17]

description:
RNAseq_20151120.D17
Sample LAP_E_29_17_4_D17


title: E IMA Rep 4 [IMA_E_45_4_4_M19]

description:
RNAseq_20151120.M19
Sample IMA_E_45_4_4_M19

source_name: primary cardiomyocytes_Imatinib

value: Imatinib


title: E LAP Rep 4 [LAP_E_43_18_4_L20]

description:
RNAseq_20151120.L20
Sample LAP_E_43_18_4_L20


title: E NIL Rep 1 [NIL_E_36_11_4_F15]

description:
RNAseq_20151120.F15
Sample NIL_E_36_11_4_F15


title: E IMA Rep 1 [IMA_E_29_3_4_D12]

description:
RNAseq_20151120.D12
Sample IMA_E_29_3_4_D12


title: E IMA Rep 3 [IMA_E_34_12_4_F7]

description:
RNAseq_20151120.F7
Sample IMA_E_34_12_4_F7


title: E PON Rep 2 [PON_E_41_18_4_J12]

description:
RNAseq_20151120.J12
Sample PON_E_41_18_4_J12


title: E GEF Rep 3 [GEF_E_36_8_4_F12]

description:
RNAseq_20151120.F12
Sample GEF_E_36_8_4_F12

source_name: primary cardiomyocytes_Gefitinib

value: Gefitinib


title: E PON Rep 3 [PON_E_43_12_4_L14]

description:
RNAseq_20151120.L14
Sample PON_E_43_12_4_L14


title: E NIL Rep 2 [NIL_E_37_7_4_G1]

description:
RNAseq_20151120.G1
Sample NIL_E_37_7_4_G1


title: E IMA Rep 2 [IMA_E_32_13_4_E20]

description:
RNAseq_20151120.E20
Sample IMA_E_32_13_4_E20


title: E GEF Rep 4 [GEF_E_37_4_4_F22]

description:
RNAseq_20151120.F22
Sample GEF_E_37_4_4_F22


title: E REG Rep 1 [REG_E_37_12_4_G6]

description:
RNAseq_20151120.G6
Sample REG_E_37_12_4_G6


title: E PON Rep 4 [PON_E_45_22_4_N3]

description:
RNAseq_20151120.N3
Sample PON_E_45_22_4_N3


title: E GEF Rep 2 [GEF_E_34_11_4_F6]

description:
RNAseq_20151120.F6
Sample GEF_E_34_11_4_F6


title: E GEF Rep 1 [GEF_E_32_12_4_E19]

description:
RNAseq_20151120.E19
Sample GEF_E_32_12_4_E19


title: E PAZ Rep 1 [PAZ_E_36_13_4_F17]

description:
RNAseq_20151120.F17
Sample PAZ_E_36_13_4_F17


title: E ERL Rep 2 [ERL_E_36_20_4_F18]

description:
RNAseq_20151120.F18
Sample ERL_E_36_20_4_F18

value: Erlotinib


title: E ERL Rep 1 [ERL_E_32_22_4_E22]

description:
RNAseq_20151120.E22
Sample ERL_E_32_22_4_E22


title: E DAS Rep 3 [DAS_E_43_26_4_M1]

description:
RNAseq_20151120.M1
Sample DAS_E_43_26_4_M1

value: Dasatinib


title: E DAS Rep 4 [DAS_E_45_3_4_M18]

description:
RNAseq_20151120.M18
Sample DAS_E_45_3_4_M18


title: E DAS Rep 2 [DAS_E_43_25_4_L24]

description:
RNAseq_20151120.L24
Sample DAS_E_43_25_4_L24


title: E DAB Rep 3 [DAB_E_43_13_4_L15]

description:
RNAseq_20151120.L15
Sample DAB_E_43_13_4_L15

source_name: primary cardiomyocytes_Dabrafenib

value: Dabrafenib


title: E LAP Rep 1 [LAP_E_26_16_4_C23]

description:
RNAseq_20151120.C23
Sample LAP_E_26_16_4_C23


title: E DAB Rep 1 [DAB_E_37_15_4_G8]

description:
RNAseq_20151120.G8
Sample DAB_E_37_15_4_G8


title: E CTRL Rep 14 [CTRL_E_47_1_4_N21]

description:
RNAseq_20151120.N21
Sample CTRL_E_47_1_4_N21

source_name: primary cardiomyocytes_Vehicle Control

value: Vehicle Control


title: E DAB Rep 2 [DAB_E_41_19_4_J13]

description:
RNAseq_20151120.J13
Sample DAB_E_41_19_4_J13


title: E DAS Rep 1 [DAS_E_41_4_4_J3]

description:
RNAseq_20151120.J3
Sample DAS_E_41_4_4_J3


title: E CTRL Rep 9 [CTRL_E_41_1_4_I24]

description:
RNAseq_20151120.I24
Sample CTRL_E_41_1_4_I24


title: E CTRL Rep 6 [CTRL_E_36_1_4_F10]

description:
RNAseq_20151120.F10
Sample CTRL_E_36_1_4_F10


title: E CTRL Rep 12 [CTRL_E_43_2_4_L4]

description:
RNAseq_20151120.L4
Sample CTRL_E_43_2_4_L4


title: E CTRL Rep 8 [CTRL_E_37_2_4_F20]

description:
RNAseq_20151120.F20
Sample CTRL_E_37_2_4_F20


title: E CTRL Rep 7 [CTRL_E_37_1_4_F19]

description:
RNAseq_20151120.F19
Sample CTRL_E_37_1_4_F19


title: E CTRL Rep 11 [CTRL_E_43_1_4_L3]

description:
RNAseq_20151120.L3
Sample CTRL_E_43_1_4_L3


title: E CTRL Rep 5 [CTRL_E_34_1_4_F4]

description:
RNAseq_20151120.F4
Sample CTRL_E_34_1_4_F4


title: E CTRL Rep 3 [CTRL_E_29_1_4_D11]

description:
RNAseq_20151120.D11
Sample CTRL_E_29_1_4_D11


title: E ERL Rep 3 [ERL_E_41_3_4_J2]

description:
RNAseq_20151120.J2
Sample ERL_E_41_3_4_J2


title: E CTRL Rep 1 [CTRL_E_26_1_4_C22]

description:
RNAseq_20151120.C22
Sample CTRL_E_26_1_4_C22


title: E CTRL Rep 4 [CTRL_E_32_1_4_E17]

description:
RNAseq_20151120.E17
Sample CTRL_E_32_1_4_E17


title: E CRI Rep 4 [CRI_E_43_3_4_L5]

description:
RNAseq_20151120.L5
Sample CRI_E_43_3_4_L5

source_name: primary cardiomyocytes_Crizotinib

value: Crizotinib


title: E CRI Rep 3 [CRI_E_29_22_4_D19]

description:
RNAseq_20151120.D19
Sample CRI_E_29_22_4_D19


title: E CTRL Rep 2 [CTRL_E_27_1_4_D2]

description:
RNAseq_20151120.D2
Sample CTRL_E_27_1_4_D2


title: E CRI Rep 2 [CRI_E_27_24_4_D7]

description:
RNAseq_20151120.D7
Sample CRI_E_27_24_4_D7


title: E CRI Rep 1 [CRI_E_26_24_4_D1]

description:
RNAseq_20151120.D1
Sample CRI_E_26_24_4_D1


title: E CER Rep 4 [CER_E_47_24_4_O8]

description:
RNAseq_20151120.O8
Sample CER_E_47_24_4_O8

value: Ceritinib


title: E DAB Rep 4 [DAB_E_47_20_4_O4]

description:
RNAseq_20151120.O4
Sample DAB_E_47_20_4_O4


title: E CTRL Rep 10 [CTRL_E_41_2_4_J1]

description:
RNAseq_20151120.J1
Sample CTRL_E_41_2_4_J1


title: E CER Rep 1 [CER_E_37_22_4_G12]

description:
RNAseq_20151120.G12
Sample CER_E_37_22_4_G12


title: E CER Rep 3 [CER_E_43_17_4_L19]

description:
RNAseq_20151120.L19
Sample CER_E_43_17_4_L19


title: E CAB Rep 4 [CAB_E_47_22_4_O6]

description:
RNAseq_20151120.O6
Sample CAB_E_47_22_4_O6

value: Cabozantinib


title: E CER Rep 2 [CER_E_41_24_4_J17]

description:
RNAseq_20151120.J17
Sample CER_E_41_24_4_J17


title: E CAB Rep 3 [CAB_E_43_15_4_L17]

description:
RNAseq_20151120.L17
Sample CAB_E_43_15_4_L17


title: E CAB Rep 1 [CAB_E_37_18_4_G10]

description:
RNAseq_20151120.G10
Sample CAB_E_37_18_4_G10


title: E CAB Rep 2 [CAB_E_41_22_4_J15]

description:
RNAseq_20151120.J15
Sample CAB_E_41_22_4_J15


title: E BOS Rep 3 [BOS_E_41_7_4_J4]

description:
RNAseq_20151120.J4
Sample BOS_E_41_7_4_J4

source_name: primary cardiomyocytes_Bosutinib

value: Bosutinib


title: E BOS Rep 4 [BOS_E_43_4_4_L6]

description:
RNAseq_20151120.L6
Sample BOS_E_43_4_4_L6


title: E BOS Rep 1 [BOS_E_36_9_4_F13]

description:
RNAseq_20151120.F13
Sample BOS_E_36_9_4_F13


title: E BOS Rep 2 [BOS_E_37_5_4_F23]

description:
RNAseq_20151120.F23
Sample BOS_E_37_5_4_F23


title: E AXI Rep 2 [AXI_E_37_8_4_G2]

description:
RNAseq_20151120.G2
Sample AXI_E_37_8_4_G2

source_name: primary cardiomyocytes_Axitinib

value: Axitinib


title: E AXI Rep 3 [AXI_E_41_10_4_J7]

description:
RNAseq_20151120.J7
Sample AXI_E_41_10_4_J7

value: Heart


title: E AXI Rep 4 [AXI_E_43_7_4_L9]

description:
RNAseq_20151120.L9
Sample AXI_E_43_7_4_L9

value: cardiac myocytes


title: E AFA Rep 2 [AFA_E_41_15_4_J10]

description:
RNAseq_20151120.J10
Sample AFA_E_41_15_4_J10

value: Afatinib


title: E AFA Rep 1 [AFA_E_37_11_4_G5]

description:
RNAseq_20151120.G5
Sample AFA_E_37_11_4_G5

value: PromoCell


title: E AXI Rep 1 [AXI_E_36_12_4_F16]

description:
RNAseq_20151120.F16
Sample AXI_E_36_12_4_F16


title: E AFA Rep 4 [AFA_E_47_18_4_O3]

description:
RNAseq_20151120.O3
Sample AFA_E_47_18_4_O3


title: E AFA Rep 3 [AFA_E_43_10_4_L12]

description:
RNAseq_20151120.L12
Sample AFA_E_43_10_4_L12


title: D VAN Rep 4 [VAN_D_42_26_4_K18]

description:
RNAseq_20151120.K18
Sample VAN_D_42_26_4_K18

source_name: primary cardiomyocytes_Vandetanib

value: Vandetanib


title: D VEM Rep 4 [VEM_D_42_30_4_K22]

description:
RNAseq_20151120.K22
Sample VEM_D_42_30_4_K22

source_name: primary cardiomyocytes_Vemurafenib

value: Vemurafenib


title: D VEM Rep 2 [VEM_D_39_33_4_I2]

description:
RNAseq_20151120.I2
Sample VEM_D_39_33_4_I2


title: D VAN Rep 1 [VAN_D_30_20_4_E3]

description:
RNAseq_20151120.E3
Sample VAN_D_30_20_4_E3


title: D TRA Rep 4 [TRA_D_42_32_4_K24]

description:
RNAseq_20151120.K24
Sample TRA_D_42_32_4_K24

source_name: primary cardiomyocytes_Trametinib

value: Trametinib


title: D VAN Rep 2 [VAN_D_39_11_4_H5]

description:
RNAseq_20151120.H5
Sample VAN_D_39_11_4_H5


title: D VEM Rep 3 [VEM_D_42_29_4_K21]

description:
RNAseq_20151120.K21
Sample VEM_D_42_29_4_K21


title: D TRA Rep 3 [TRA_D_42_17_4_K10]

description:
RNAseq_20151120.K10
Sample TRA_D_42_17_4_K10


title: D TOF Rep 3 [TOF_D_42_4_4_J21]

description:
RNAseq_20151120.J21
Sample TOF_D_42_4_4_J21

source_name: primary cardiomyocytes_Tofacitinib

value: Tofacitinib


title: D TRA Rep 2 [TRA_D_39_35_4_I4]

description:
RNAseq_20151120.I4
Sample TRA_D_39_35_4_I4


title: D TOF Rep 4 [TOF_D_42_23_4_K15]

description:
RNAseq_20151120.K15
Sample TOF_D_42_23_4_K15


title: D TRA Rep 1 [TRA_D_39_23_4_H17]

description:
RNAseq_20151120.H17
Sample TRA_D_39_23_4_H17


title: D SUN Rep 4 [SUN_D_48_27_4_O15]

description:
RNAseq_20151120.O15
Sample SUN_D_48_27_4_O15

source_name: primary cardiomyocytes_Sunitinib

value: Sunitinib


title: D TOF Rep 2 [TOF_D_39_8_4_H2]

description:
RNAseq_20151120.H2
Sample TOF_D_39_8_4_H2


title: D TOF Rep 1 [TOF_D_30_17_4_D24]

description:
RNAseq_20151120.D24
Sample TOF_D_30_17_4_D24


title: D VEM Rep 1 [VEM_D_39_21_4_H15]

description:
RNAseq_20151120.H15
Sample VEM_D_39_21_4_H15


title: D SOR Rep 3 [SOR_D_30_11_4_D22]

description:
RNAseq_20151120.D22
Sample SOR_D_30_11_4_D22

value: Sorafenib


title: D SOR Rep 4 [SOR_D_48_12_4_O13]

description:
RNAseq_20151120.O13
Sample SOR_D_48_12_4_O13


title: D SUN Rep 2 [SUN_D_42_20_4_K13]

description:
RNAseq_20151120.K13
Sample SUN_D_42_20_4_K13


title: D SOR Rep 1 [SOR_D_19_3_4_B16]

description:
RNAseq_20151120.B16
Sample SOR_D_19_3_4_B16


title: D SOR Rep 2 [SOR_D_25_2_4_C19]

description:
RNAseq_20151120.C19
Sample SOR_D_25_2_4_C19


title: D VAN Rep 3 [VAN_D_42_7_4_J24]

description:
RNAseq_20151120.J24
Sample VAN_D_42_7_4_J24


title: D RUX Rep 1 [RUX_D_30_24_4_E7]

description:
RNAseq_20151120.E7
Sample RUX_D_30_24_4_E7

source_name: primary cardiomyocytes_Ruxolitinib

value: Ruxolitinib


title: D REG Rep 4 [REG_D_42_13_4_K6]

description:
RNAseq_20151120.K6
Sample REG_D_42_13_4_K6

value: Regorafenib


title: D REG Rep 1 [REG_D_30_26_4_E9]

description:
RNAseq_20151120.E9
Sample REG_D_30_26_4_E9


title: D REG Rep 2 [REG_D_39_18_4_H12]

description:
RNAseq_20151120.H12
Sample REG_D_39_18_4_H12


title: D RUX Rep 2 [RUX_D_39_16_4_H10]

description:
RNAseq_20151120.H10
Sample RUX_D_39_16_4_H10


title: E CTRL Rep 13 [CTRL_E_45_1_4_M17]

description:
RNAseq_20151120.M17
Sample CTRL_E_45_1_4_M17

value: Vehicle Control


title: D RUX Rep 3 [RUX_D_39_28_4_H21]

description:
RNAseq_20151120.H21
Sample RUX_D_39_28_4_H21


title: D SUN Rep 1 [SUN_D_39_6_4_G24]

description:
RNAseq_20151120.G24
Sample SUN_D_39_6_4_G24


title: D REG Rep 3 [REG_D_39_30_4_H23]

description:
RNAseq_20151120.H23
Sample REG_D_39_30_4_H23


title: D PON Rep 2 [PON_D_39_31_4_H24]

description:
RNAseq_20151120.H24
Sample PON_D_39_31_4_H24

source_name: primary cardiomyocytes_Ponatinib

value: Ponatinib


title: D PON Rep 3 [PON_D_42_14_4_K7]

description:
RNAseq_20151120.K7
Sample PON_D_42_14_4_K7


title: D PAZ Rep 3 [PAZ_D_39_27_4_H20]

description:
RNAseq_20151120.H20
Sample PAZ_D_39_27_4_H20

source_name: primary cardiomyocytes_Pazopanib

value: Pazopanib


title: D SUN Rep 3 [SUN_D_48_4_4_O12]

description:
RNAseq_20151120.O12
Sample SUN_D_48_4_4_O12


title: D PON Rep 1 [PON_D_39_19_4_H13]

description:
RNAseq_20151120.H13
Sample PON_D_39_19_4_H13


title: D PAZ Rep 2 [PAZ_D_39_15_4_H9]

description:
RNAseq_20151120.H9
Sample PAZ_D_39_15_4_H9


title: D RUX Rep 4 [RUX_D_42_11_4_K4]

description:
RNAseq_20151120.K4
Sample RUX_D_42_11_4_K4


title: D NIL Rep 4 [NIL_D_42_8_4_K1]

description:
RNAseq_20151120.K1
Sample NIL_D_42_8_4_K1

source_name: primary cardiomyocytes_Nilotinib

value: Nilotinib


title: D NIL Rep 3 [NIL_D_39_13_4_H7]

description:
RNAseq_20151120.H7
Sample NIL_D_39_13_4_H7


title: D PAZ Rep 1 [PAZ_D_30_23_4_E6]

description:
RNAseq_20151120.E6
Sample PAZ_D_30_23_4_E6


title: D NIL Rep 2 [NIL_D_39_12_4_H6]

description:
RNAseq_20151120.H6
Sample NIL_D_39_12_4_H6


title: D IMA Rep 2 [IMA_D_13_16_4_B4]

description:
RNAseq_20151120.B4
Sample IMA_D_13_16_4_B4

value: Imatinib


title: D GEF Rep 4 [GEF_D_42_24_4_K16]

description:
RNAseq_20151120.K16
Sample GEF_D_42_24_4_K16

value: Heart

value: Gefitinib


title: D PON Rep 4 [PON_D_42_27_4_K19]

description:
RNAseq_20151120.K19
Sample PON_D_42_27_4_K19

value: cardiac myocytes


title: D GEF Rep 2 [GEF_D_39_9_4_H3]

description:
RNAseq_20151120.H3
Sample GEF_D_39_9_4_H3

value: PromoCell


title: D IMA Rep 1 [IMA_D_9_23_4_A8]

description:
RNAseq_20151120.A8
Sample IMA_D_9_23_4_A8


title: D IMA Rep 4 [IMA_D_28_6_4_D10]

description:
RNAseq_20151120.D10
Sample IMA_D_28_6_4_D10


title: D GEF Rep 1 [GEF_D_30_18_4_E1]

description:
RNAseq_20151120.E1
Sample GEF_D_30_18_4_E1


title: D PAZ Rep 4 [PAZ_D_42_10_4_K3]

description:
RNAseq_20151120.K3
Sample PAZ_D_42_10_4_K3


title: D DAS Rep 4 [DAS_D_48_26_4_O14]

description:
RNAseq_20151120.O14
Sample DAS_D_48_26_4_O14

source_name: primary cardiomyocytes_Dasatinib

value: Dasatinib


title: D ERL Rep 4 [ERL_D_42_21_4_K14]

description:
RNAseq_20151120.K14
Sample ERL_D_42_21_4_K14

source_name: primary cardiomyocytes_Erlotinib

value: Erlotinib


title: D ERL Rep 1 [ERL_D_28_3_4_D9]

description:
RNAseq_20151120.D9
Sample ERL_D_28_3_4_D9


title: D ERL Rep 2 [ERL_D_30_3_4_D21]

description:
RNAseq_20151120.D21
Sample ERL_D_30_3_4_D21


title: D DAS Rep 1 [DAS_D_42_19_4_K12]

description:
RNAseq_20151120.K12
Sample DAS_D_42_19_4_K12


title: D ERL Rep 3 [ERL_D_39_3_4_G23]

description:
RNAseq_20151120.G23
Sample ERL_D_39_3_4_G23


title: D DAS Rep 3 [DAS_D_48_3_4_O11]

description:
RNAseq_20151120.O11
Sample DAS_D_48_3_4_O11


title: D DAS Rep 2 [DAS_D_42_34_4_L2]

description:
RNAseq_20151120.L2
Sample DAS_D_42_34_4_L2


title: D IMA Rep 3 [IMA_D_25_12_4_C21]

description:
RNAseq_20151120.C21
Sample IMA_D_25_12_4_C21

source_name: primary cardiomyocytes_Imatinib


title: D DAB Rep 3 [DAB_D_42_15_4_K8]

description:
RNAseq_20151120.K8
Sample DAB_D_42_15_4_K8

source_name: primary cardiomyocytes_Dabrafenib

value: Dabrafenib


title: D DAB Rep 4 [DAB_D_42_28_4_K20]

description:
RNAseq_20151120.K20
Sample DAB_D_42_28_4_K20


title: D NIL Rep 1 [NIL_D_30_21_4_E4]

description:
RNAseq_20151120.E4
Sample NIL_D_30_21_4_E4


title: D DAB Rep 1 [DAB_D_39_20_4_H14]

description:
RNAseq_20151120.H14
Sample DAB_D_39_20_4_H14


title: D CTRL Rep 13 [CTRL_D_48_2_4_O10]

description:
RNAseq_20151120.O10
Sample CTRL_D_48_2_4_O10

source_name: primary cardiomyocytes_Vehicle Control


title: D CTRL Rep 11 [CTRL_D_42_2_4_J19]

description:
RNAseq_20151120.J19
Sample CTRL_D_42_2_4_J19


title: D CTRL Rep 12 [CTRL_D_48_1_4_O9]

description:
RNAseq_20151120.O9
Sample CTRL_D_48_1_4_O9


title: D GEF Rep 3 [GEF_D_42_5_4_J22]

description:
RNAseq_20151120.J22
Sample GEF_D_42_5_4_J22

source_name: primary cardiomyocytes_Gefitinib


title: D CTRL Rep 10 [CTRL_D_42_1_4_J18]

description:
RNAseq_20151120.J18
Sample CTRL_D_42_1_4_J18


title: D CTRL Rep 7 [CTRL_D_30_1_4_D20]

description:
RNAseq_20151120.D20
Sample CTRL_D_30_1_4_D20


title: D CTRL Rep 8 [CTRL_D_39_1_4_G21]

description:
RNAseq_20151120.G21
Sample CTRL_D_39_1_4_G21


title: D CTRL Rep 9 [CTRL_D_39_2_4_G22]

description:
RNAseq_20151120.G22
Sample CTRL_D_39_2_4_G22


title: D CTRL Rep 6 [CTRL_D_28_1_4_D8]

description:
RNAseq_20151120.D8
Sample CTRL_D_28_1_4_D8


title: D CTRL Rep 4 [CTRL_D_19_1_4_B15]

description:
RNAseq_20151120.B15
Sample CTRL_D_19_1_4_B15


title: D CTRL Rep 5 [CTRL_D_25_1_4_C18]

description:
RNAseq_20151120.C18
Sample CTRL_D_25_1_4_C18


title: D CTRL Rep 3 [CTRL_D_15_1_4_B10]

description:
RNAseq_20151120.B10
Sample CTRL_D_15_1_4_B10


title: D CTRL Rep 2 [CTRL_D_13_2_4_B3]

description:
RNAseq_20151120.B3
Sample CTRL_D_13_2_4_B3


title: D CRI Rep 4 [CRI_D_42_3_4_J20]

description:
RNAseq_20151120.J20
Sample CRI_D_42_3_4_J20

source_name: primary cardiomyocytes_Crizotinib

value: Crizotinib


title: D CTRL Rep 1 [CTRL_D_9_1_4_A7]

description:
RNAseq_20151120.A7
Sample CTRL_D_9_1_4_A7


title: D CER Rep 3 [CER_D_42_18_4_K11]

description:
RNAseq_20151120.K11
Sample CER_D_42_18_4_K11

source_name: primary cardiomyocytes_Ceritinib

value: Ceritinib


title: D CER Rep 4 [CER_D_42_33_4_L1]

description:
RNAseq_20151120.L1
Sample CER_D_42_33_4_L1


title: D DAB Rep 2 [DAB_D_39_32_4_I1]

description:
RNAseq_20151120.I1
Sample DAB_D_39_32_4_I1


title: D CRI Rep 1 [CRI_D_13_17_4_B5]

description:
RNAseq_20151120.B5
Sample CRI_D_13_17_4_B5


title: D CER Rep 2 [CER_D_39_36_4_I5]

description:
RNAseq_20151120.I5
Sample CER_D_39_36_4_I5


title: D CRI Rep 2 [CRI_D_30_16_4_D23]

description:
RNAseq_20151120.D23
Sample CRI_D_30_16_4_D23


title: D CRI Rep 3 [CRI_D_39_7_4_H1]

description:
RNAseq_20151120.H1
Sample CRI_D_39_7_4_H1


title: D CER Rep 1 [CER_D_39_24_4_H18]

description:
RNAseq_20151120.H18
Sample CER_D_39_24_4_H18


title: D CAB Rep 4 [CAB_D_42_31_4_K23]

description:
RNAseq_20151120.K23
Sample CAB_D_42_31_4_K23

source_name: primary cardiomyocytes_Cabozantinib

value: Cabozantinib


title: D CAB Rep 1 [CAB_D_39_22_4_H16]

description:
RNAseq_20151120.H16
Sample CAB_D_39_22_4_H16


title: D CAB Rep 3 [CAB_D_42_16_4_K9]

description:
RNAseq_20151120.K9
Sample CAB_D_42_16_4_K9


title: D CAB Rep 2 [CAB_D_39_34_4_I3]

description:
RNAseq_20151120.I3
Sample CAB_D_39_34_4_I3


title: D BOS Rep 4 [BOS_D_42_25_4_K17]

description:
RNAseq_20151120.K17
Sample BOS_D_42_25_4_K17

source_name: primary cardiomyocytes_Bosutinib

value: Bosutinib


title: D BOS Rep 2 [BOS_D_39_10_4_H4]

description:
RNAseq_20151120.H4
Sample BOS_D_39_10_4_H4


title: D BOS Rep 3 [BOS_D_42_6_4_J23]

description:
RNAseq_20151120.J23
Sample BOS_D_42_6_4_J23


title: D AXI Rep 3 [AXI_D_39_26_4_H19]

description:
RNAseq_20151120.H19
Sample AXI_D_39_26_4_H19

source_name: primary cardiomyocytes_Axitinib

value: Axitinib


title: D AXI Rep 4 [AXI_D_42_9_4_K2]

description:
RNAseq_20151120.K2
Sample AXI_D_42_9_4_K2


title: D AXI Rep 1 [AXI_D_30_22_4_E5]

description:
RNAseq_20151120.E5
Sample AXI_D_30_22_4_E5


title: D AXI Rep 2 [AXI_D_39_14_4_H8]

description:
RNAseq_20151120.H8
Sample AXI_D_39_14_4_H8


title: D AFA Rep 4 [AFA_D_42_12_4_K5]

description:
RNAseq_20151120.K5
Sample AFA_D_42_12_4_K5

source_name: primary cardiomyocytes_Afatinib

value: Afatinib


title: D AFA Rep 2 [AFA_D_39_17_4_H11]

description:
RNAseq_20151120.H11
Sample AFA_D_39_17_4_H11


title: D AFA Rep 3 [AFA_D_39_29_4_H22]

description:
RNAseq_20151120.H22
Sample AFA_D_39_29_4_H22


title: D AFA Rep 1 [AFA_D_30_25_4_E8]

description:
RNAseq_20151120.E8
Sample AFA_D_30_25_4_E8


title: B VEM Rep 2 [VEM_B_44_19_4_M13]

description:
RNAseq_20151120.M13
Sample VEM_B_44_19_4_M13

source_name: primary cardiomyocytes_Vemurafenib

value: Vemurafenib


title: B VEM Rep 4 [VEM_B_50_14_4_P5]

description:
RNAseq_20151120.P5
Sample VEM_B_50_14_4_P5


title: B VEM Rep 1 [VEM_B_40_18_4_I19]

description:
RNAseq_20151120.I19
Sample VEM_B_40_18_4_I19


title: D BOS Rep 1 [BOS_D_30_19_4_E2]

description:
RNAseq_20151120.E2
Sample BOS_D_30_19_4_E2


title: B TRA Rep 2 [TRA_B_44_21_4_M15]

description:
RNAseq_20151120.M15
Sample TRA_B_44_21_4_M15

source_name: primary cardiomyocytes_Trametinib

value: Trametinib


title: B TRA Rep 4 [TRA_B_50_16_4_P7]

description:
RNAseq_20151120.P7
Sample TRA_B_50_16_4_P7


title: B TRA Rep 1 [TRA_B_40_20_4_I21]

description:
RNAseq_20151120.I21
Sample TRA_B_40_20_4_I21


title: B TRA Rep 3 [TRA_B_46_20_4_N19]

description:
RNAseq_20151120.N19
Sample TRA_B_46_20_4_N19


title: B REG Rep 2 [REG_B_44_16_4_M10]

description:
RNAseq_20151120.M10
Sample REG_B_44_16_4_M10

source_name: primary cardiomyocytes_Regorafenib

value: Regorafenib


title: B REG Rep 1 [REG_B_40_13_4_I16]

description:
RNAseq_20151120.I16
Sample REG_B_40_13_4_I16


title: B PON Rep 3 [PON_B_46_16_4_N15]

description:
RNAseq_20151120.N15
Sample PON_B_46_16_4_N15

source_name: primary cardiomyocytes_Ponatinib

value: Ponatinib


title: B RUX Rep 3 [RUX_B_46_13_4_N12]

description:
RNAseq_20151120.N12
Sample RUX_B_46_13_4_N12

source_name: primary cardiomyocytes_Ruxolitinib

value: Heart

value: Ruxolitinib


title: B PON Rep 2 [PON_B_44_17_4_M11]

description:
RNAseq_20151120.M11
Sample PON_B_44_17_4_M11

value: cardiac myocytes


title: B PON Rep 1 [PON_B_40_14_4_I17]

description:
RNAseq_20151120.I17
Sample PON_B_40_14_4_I17

value: PromoCell


title: B PON Rep 4 [PON_B_50_12_4_P3]

description:
RNAseq_20151120.P3
Sample PON_B_50_12_4_P3


title: B REG Rep 3 [REG_B_46_15_4_N14]

description:
RNAseq_20151120.N14
Sample REG_B_46_15_4_N14


title: B RUX Rep 1 [RUX_B_40_11_4_I14]

description:
RNAseq_20151120.I14
Sample RUX_B_40_11_4_I14


title: B REG Rep 4 [REG_B_50_11_4_P2]

description:
RNAseq_20151120.P2
Sample REG_B_50_11_4_P2


title: B RUX Rep 2 [RUX_B_44_14_4_M8]

description:
RNAseq_20151120.M8
Sample RUX_B_44_14_4_M8


title: B RUX Rep 4 [RUX_B_50_9_4_O23]

description:
RNAseq_20151120.O23
Sample RUX_B_50_9_4_O23


title: B PAZ Rep 3 [PAZ_B_46_12_4_N11]

description:
RNAseq_20151120.N11
Sample PAZ_B_46_12_4_N11

source_name: primary cardiomyocytes_Pazopanib

value: Pazopanib


title: B PAZ Rep 2 [PAZ_B_44_13_4_M7]

description:
RNAseq_20151120.M7
Sample PAZ_B_44_13_4_M7


title: B NIL Rep 4 [NIL_B_50_6_4_O20]

description:
RNAseq_20151120.O20
Sample NIL_B_50_6_4_O20

source_name: primary cardiomyocytes_Nilotinib

value: Nilotinib


title: B PAZ Rep 4 [PAZ_B_50_8_4_O22]

description:
RNAseq_20151120.O22
Sample PAZ_B_50_8_4_O22


title: B NIL Rep 3 [NIL_B_46_10_4_N9]

description:
RNAseq_20151120.N9
Sample NIL_B_46_10_4_N9


title: B NIL Rep 2 [NIL_B_44_11_4_M5]

description:
RNAseq_20151120.M5
Sample NIL_B_44_11_4_M5


title: B NIL Rep 1 [NIL_B_40_8_4_I11]

description:
RNAseq_20151120.I11
Sample NIL_B_40_8_4_I11


title: B IMA Rep 4 [IMA_B_46_6_4_N6]

description:
RNAseq_20151120.N6
Sample IMA_B_46_6_4_N6

source_name: primary cardiomyocytes_Imatinib

value: Imatinib


title: B IMA Rep 2 [IMA_B_23_9_4_C10]

description:
RNAseq_20151120.C10
Sample IMA_B_23_9_4_C10


title: B IMA Rep 3 [IMA_B_33_21_4_F1]

description:
RNAseq_20151120.F1
Sample IMA_B_33_21_4_F1


title: B GEF Rep 4 [GEF_B_44_7_4_M4]

description:
RNAseq_20151120.M4
Sample GEF_B_44_7_4_M4

value: Gefitinib


title: B GEF Rep 3 [GEF_B_40_6_4_I10]

description:
RNAseq_20151120.I10
Sample GEF_B_40_6_4_I10


title: B PAZ Rep 1 [PAZ_B_40_10_4_I13]

description:
RNAseq_20151120.I13
Sample PAZ_B_40_10_4_I13